EP2626422A1 - Zusammensetzungen und Verfahren mit Cellulasevarianten mit verminderter Affinität gegenüber cellulosefreien Materialien - Google Patents

Zusammensetzungen und Verfahren mit Cellulasevarianten mit verminderter Affinität gegenüber cellulosefreien Materialien Download PDF

Info

Publication number
EP2626422A1
EP2626422A1 EP13167128.1A EP13167128A EP2626422A1 EP 2626422 A1 EP2626422 A1 EP 2626422A1 EP 13167128 A EP13167128 A EP 13167128A EP 2626422 A1 EP2626422 A1 EP 2626422A1
Authority
EP
European Patent Office
Prior art keywords
cbh2
cellulase
variant
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13167128.1A
Other languages
English (en)
French (fr)
Inventor
Luis Cascao-Pereira
Thijs Kaper
Bradley R. Kelemen
Amy Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danisco US Inc
Original Assignee
Danisco US Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco US Inc filed Critical Danisco US Inc
Publication of EP2626422A1 publication Critical patent/EP2626422A1/de
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/02—Monosaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01091—Cellulose 1,4-beta-cellobiosidase (3.2.1.91)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Definitions

  • the present disclosure relates to enzymes and in particular cellulase variants. Also described are nucleic acids encoding the cellulase variants, compositions comprising the cellulase variants, methods of identifying additional useful cellulase variants and methods of using the compositions.
  • Cellulose and hemicellulose are the most abundant plant materials produced by photosynthesis. They can be degraded and used as an energy source by numerous microorganisms (e.g., bacteria, yeast and fungi) that produce extracellular enzymes capable of hydrolysis of the polymeric substrates to monomeric sugars ( Aro et al., J Biol Chem, 276: 24309-24314, 2001 ). As the limits of non-renewable resources approach, the potential of cellulose to become a major renewable energy resource is enormous ( Krishna et al., Bioresource Tech, 77: 193-196, 2001 ). The effective utilization of cellulose through biological processes is one approach to overcoming the shortage of foods, feeds, and fuels ( Ohmiya et al., Biotechnol Gen Engineer Rev, 14: 365-414, 1997 ).
  • Cellulases are enzymes that hydrolyze cellulose (beta-1,4-glucan or beta D-glucosidic linkages) resulting in the formation of glucose, cellobiose, cellooligosaccharides, and the like.
  • Cellulases have been traditionally divided into three major classes: endoglucanases (EC 3.2.1.4) (“EG”), exoglucanases or cellobiohydrolases (EC 3.2.1.91) (“CBH”) and beta-glucosidases ([beta]-D-glucoside glucohydrolase; EC 3.2.1.21) (“BG”).
  • Endoglucanases act mainly on the amorphous parts of the cellulose fibre, whereas cellobiohydrolases are also able to degrade crystalline cellulose ( Nevalainen and Penttila, Mycota, 303-319, 1995 ).
  • a cellobiohydrolase in a cellulase system is required for efficient solubilization of crystalline cellulose ( Suurnakki et al., Cellulose 7: 189-209, 2000 ).
  • Beta-glucosidase acts to liberate D-glucose units from cellobiose, cellooligosaccharides, and other glucosides ( Freer, J Biol Chem, 268: 9337-9342, 1993 ).
  • Cellulases are known to be produced by a large number of bacteria, yeast and fungi. Certain fungi produce a complete cellulase system capable of degrading crystalline forms of cellulose, such that the cellulases are readily produced in large quantities via fermentation. Filamentous fungi play a special role since many yeast, such as Saccharomyces cerevisiae, lack the ability to hydrolyze cellulose (See, e.g., Wood et al., Methods in Enzymology, 160: 87-116, 1988 ).
  • the fungal cellulase classifications of CBH, EG and BG can be further expanded to include multiple components within each classification.
  • multiple CBHs, EGs and BGs have been isolated from a variety of fungal sources including Trichoderma reesei (also referred to as Hypocrea jecorina ), which contains known genes for two CBHs, i.e., CBH I ("CBH1") and CBH II ("CBH2”), at least 8 EGs, i.e., EG I, EG II, EG III, EGIV, EGV, EGVI, EGVII and EGVIII, and at least 5 BGs, i.e., BG1, BG2, BG3, BG4 and BG5.
  • EGIV, EGVI and EGVIII also have xyloglucanase activity.
  • the complete cellulase system comprising components from each of the CBH, EG and BG classifications is required, with isolated components less effective in hydrolyzing crystalline cellulose ( Filho et al., Can J Microbiol, 42:1-5, 1996 ).
  • a synergistic relationship has been observed between cellulase components from different classifications.
  • the EG-type cellulases and CBH-type cellulases synergistically interact to more efficiently degrade cellulose.
  • Cellulases are known in the art to be useful in the treatment of textiles for the purposes of enhancing the cleaning ability of detergent compositions, for use as a softening agent, for improving the feel and appearance of cotton fabrics, and the like ( Kumar et al., Textile Chemist and Colorist, 29:37-42, 1997 ).
  • Cellulase-containing detergent compositions with improved cleaning performance U.S. Pat. No. 4,435,307 ; GB App. Nos. 2,095,275 and 2,094,826
  • U.S. Pat. Nos. 5,648,263 , 5,691,178 , and 5,776,757 U.S. Pat. Nos. 5,648,263 , 5,691,178 , and 5,776,757 ; and GB App. No.
  • Trichoderma spp. e.g., Trichoderma longibrachiatum or Trichoderma reesei
  • Trichoderma spp. e.g., Trichoderma longibrachiatum or Trichoderma reesei
  • the present teachings relates to cellulase variants modified to reduce binding to non-cellulosic materials.
  • the cellulase variants have increased cellulolytic activity in the presence of non-cellulosic materials in comparison to wild type cellulases.
  • the cellulase variants have a decreased net charge (i.e. is more negative) in comparison to wild type cellulases.
  • the cellulase variants are less positively charged than wild type cellulases.
  • a cellulase is modified by removing one or more positive charges.
  • a cellulase is modified by adding one or more negative charges.
  • a cellulase is modified by removing one or more positive charges and adding one or more negative charges.
  • the present teachings relate to cellobiohydrolase I (CBH1) or cellobiohydrolase II (CBH2) variants.
  • the cellulase variant is a mature form having cellulase activity and a substitution at one or more positions selected from the group consisting of 63, 77, 129, 147, 153, 157, 161, 194, 197, 203, 237, 239, 247, 254, 281, 285, 288, 289, 294, 327, 339, 344, 356, 378, and 382, wherein the positions are numbered by correspondence to a reference (e.g., wild type Hypocrea jecorina CBH2) cellulase having the amino acid sequence of SEQ ID NO:3, and wherein the substitution at one or more positions causes the cellulase variant to have a more negative net charge in comparison to the reference cellulase.
  • a reference e.g., wild type Hypocrea jecorina CBH2
  • CBH2 is modified by removing one or more positive charges, which in some embodiments entails a replacement of a lysine or an arginine with a neutral amino acid (e.g., K or R replaced by N or Q or other neutral residue).
  • CBH2 is modified by adding one or more negative charges, which in some embodiments entails a replacement of a neutral amino acid with a negatively charged amino acid (e.g., No or Q or other neutral residue replaced by D or E).
  • CBH2 is modified by removing one or more positive charges and adding one or more negative charges, which in some embodiments entails a replacement of a lysine or an arginine with a negatively charged amino acid (e.g., K or R replaced by D or E).
  • a negatively charged amino acid e.g., K or R replaced by D or E.
  • the CBH2 variant has increased cellulolytic activity in the presence of lignin in comparison to the wild type Hypocrea jecorina CBH2 having the amino acid sequence of SEQ ID NO:3.
  • the present teachings further provide CBH2 variants comprising one or more substitutions selected from the group consisting of K129E, K157E, K194E, K288E, K327E, K356E, R63Q, R77Q, R153Q, R203Q, R294Q, R378Q, N161D, N197D, N237D, N247D, N254D, N285D, N289D, N339D, N344D, N382D, Q147E, Q204E, Q239E, Q281E, D151N, D189N, D211N, D277N, D405N, E146Q, E208Q, and E244Q, in the mature form of CBH2, wherein said substitutions are numbered according to the mature form of Hypocrea jecorina CBH2 of SEQ ID NO:3.
  • the variant comprises a further substitution at one or more further positions selected from the group consisting of 146, 151, 189, 208, 211, 244, 277 and 405, wherein the further positions are numbered by correspondence with the amino acid sequence of the reference cellobiohydrolase II (CBH2) set forth as SEQ ID NO:3.
  • the further substitution at one or more further positions comprises a replacement of aspartic acid or glutamic acid with a neutral amino acid (e.g., D or E replaced by N or Q or other neutral residue).
  • the further substitution at one or more further positions comprises one or more of the group consisting of D151N, D189N, D211N, D277N, D405N, E146Q, E208Q, and E244Q, wherein the positions are numbered by correspondence with the amino acid sequence of the reference cellobiohydrolase II (CBH2) set forth as SEQ ID NO:3.
  • the substitution at one or more positions is selected from the group consisting of 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 positions.
  • the cellulase variant is derived from a parent cellulase selected from the group consisting of Hypocrea jecorina CBH2, Hypocrea koningii CBH2, Humicola insolens CBH2, Acremonium cellulolyticus CBH2, Agaricus bisporus CBH2, Fusarium osysporum EG, Phanerochaete chrysosporium CBH2, Talaromyces emersonii CBH2, Thermobifida. fusca 6B / E3 CBH2, Thermobifida fusca 6A / E2 EG, and Cellulomonas fimi CenA EG.
  • a parent cellulase selected from the group consisting of Hypocrea jecorina CBH2, Hypocrea koningii CBH2, Humicola insolens CBH2, Acremonium cellulolyticus CBH2, Agaricus bisporus CBH2, Fusarium
  • the cellulase variant is derived from a parent cellulase whose amino acid sequence is at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% identical to a member of the group consisting of SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, and SEQ ID NO:13.
  • the more negative net charge is a -1 or -2 in comparison to the reference CBH2.
  • the present disclosure further provides cellulase variants, wherein the variant is a mature form having cellulase activity and comprising a chemical modification of a lysine residue to remove positive charge of the lysine residue.
  • the chemical modification comprises a treatment with a compound selected from the group consisting of succinic anhydride, acetoxysuccinic anhydride, maleic anhydride, tartaric anhydride, phthalic anhydride, trimetallitic anhydride, cis-aconitic anhydride, t-nitrophthalic anhydride, acetic anhydride, butyric anhydride, isobutyric anhydride, hexanoic anhydride, valeric anhydride, isovaleric anhydride, and pivalic anhydride.
  • the cellulase variant is derived from a parent cellulase selected from the group consisting of a Hypocrea jecorina cellobiohydrolase I, Hypocrea jecorina cellobiohydrolase II, Hyprocrea jecorina endoglucanase I, Hypocrea jecorina endoglucanase II, and Hypocrea jecorina beta-glucosidase.
  • the cellulase variant is derived from a parent cellulase selected from the group consisting of Hypocrea jecorina CBH2, Hypocrea koningii CBH2, Humicola insolens CBH2, Acremonium cellulolyticus CBH2, Agaricus bisporus CBH2, Fusarium osysporum EG, Phanerochaete chrysosporium CBH2, Talaromyces emersonii CBH2, Thermobifida. fusca 6B / E3 CBH2, Thermobifida fusca 6A / E2 EG, and Cellulomonas fimi CenA EG.
  • a parent cellulase selected from the group consisting of Hypocrea jecorina CBH2, Hypocrea koningii CBH2, Humicola insolens CBH2, Acremonium cellulolyticus CBH2, Agaricus bisporus CBH2, Fusarium
  • cellulase variants derived from a parent cellulase whose amino acid sequence is at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% identical to a member of the group consisting of SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, and SEQ ID NO:13.
  • the cellulase variant comprises a substitution at one or more positions selected from the group consisting of 63, 77, 129, 147, 153, 157, 161, 194, 197, 203, 237, 239, 247, 254, 281, 285, 288, 289, 294, 327, 339, 344, 356, 378, and 382, wherein the positions are numbered by correspondence with the amino acid sequence of a reference cellobiohydrolase II (CBH2) set forth as SEQ ID NO:3.
  • CBH2 cellobiohydrolase II
  • the present teachings further relates to CBH2 variant comprising from one to twenty six substitutions selected from the group consisting of K129E, K157E, K194E, K288E, K327E, K356E, R63Q, R77Q, R153Q, R203Q, R294Q, R378Q, N161D, N197D, N237D, N247D, N254D, N285D, N289D, N339D, N344D, N382D, Q147E, Q204E, Q239E, and Q281E.
  • the CBH2 variant comprises a combination of substitutions selected from the group consisting of: i) K157E / K129E; ii) K157E / K129E / K288E / K194E; iii) K157E / K129E / K288E / K194E / K356E / K327E; iv) K157E / K129E / K288E / K194E / K356E / K327E / R153Q / R294Q / R203Q / R378Q; v) K157E / K129E / K288E / K194E / K356E / K327E / R153Q / R294Q / R203Q / R378Q; v) K157E / K129E / K288E / K194E / K356E / K327E / R153Q /
  • the CBH2 variant comprises from one to eight substitutions selected from the group consisting of D151N, D189N, D211N, D277N, D405N, E146Q, E208Q, and E244Q. In some embodiments, the CBH2 variant comprises a combination of substitutions selected from the group consisting: i) D189N / E208Q / D211N / D405; and ii) D189N / E208Q / D211N / D405 / E244Q / D277N / D151 / E146Q.
  • isolated nucleic acids encoding a CBH2 variant having cellobiohydrolase activity as described in the preceding paragraphs.
  • the disclosure encompasses an isolated nucleic acid encoding a polypeptide having cellobiohydrolase activity, which polypeptide is a variant of a glycosyl hydrolase of family 6, and wherein said nucleic acid encodes a substitution at a residue which decreases the net charge in comparison to the wild type Hypocrea jecorina CBH2.
  • the disclosure is directed to an isolated nucleic acid encoding a CBH2 variant, wherein said variant comprises a substitution at a position selected from the group consisting of K129E, K157E, K194E, K288E, K327E, K356E, R63Q, R77Q, R153Q, R203Q, R294Q, R378Q, N161D, N197D, N237D, N247D, N254D, N285D, N289D, N339D, N344D, N382D, Q147E, Q204E, Q239E, Q281E, D151N, D189N, D211N, D277N, D405N, E146Q, E208Q, and E244Q, in the mature form of CBH2, wherein said substitutions are numbered according to the mature form of Hypocrea jecorina CBH2 of SEQ ID NO:3.
  • the disclosure is directed to an expression cassette comprising a nucleic acid encoding a CBH2 variant, a constructs comprising the nucleic acid of encoding the CBH2 variant operably linked to a regulatory sequence, a vector comprising a nucleic acid encoding a CBH2 variant, and host cell transformed with the vector comprising a nucleic acid encoding a CBH2 variant.
  • the present teachings further provide methods producing a CBH2 variant by culturing the host cells expressing a CBH2 variant in a culture medium under suitable conditions to produce the CBH2 variant.
  • compositions comprising the cellulase variant of the preceding paragraphs.
  • the composition further comprises at least one additional enzyme selected from the group consisting of a subtilisin, a neutral metalloprotease, a lipase, a cutinase, an amylase, a carbohydrase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase, an oxidase, and a peroxidase
  • methods of converting biomass to sugars comprising contacting said biomass with a cellulase variant. Also provided are methods of producing a fuel by contacting a biomass composition with an enzymatic composition comprising the cellulase variant to yield a sugar solution and culturing with a fermentative microorganism under conditions sufficient to produce a fuel.
  • compositions comprising cellulase variants including detergent compositions, feed additives for example, and methods of cleaning or fabric care by contacting a surface and/or an article comprising a fabric with the detergent composition. Also, provided are methods of fabric care treatment, including depilling and surface finishing, by contacting a surface and/or an article comprising a fabric with a cellulase variant.
  • FIG. 1 illustrates saccharification of APB by modified (squares) and unmodified (circles) Trichoderma sp. cellulase preparations in the presence of increasing amounts of lignin inhibitor.
  • FIG. 1A and FIG. 1B shows results after 24 and 48 hour incubations, respectively.
  • FIG. 2A illustrates saccharification comparing modified cellulases
  • FIG. 2B shows the difference of saccharification using modified and unmodified cellulases.
  • FIG. 3 provides an alignment of the amino acid sequences of the mature form of various cellulases: Hypocrea jecorina (also known as T. reesei ) CBH2 (SEQ ID NO:3), Hypocrea koningii CBH2 (SEQ ID NO:4), Humicola insolens CBH2 (SEQ ID NO: 5), Acremonium cellulolyticus CBH2 (SEQ ID NO:6), Agaricus bisporus CBH2 (SEQ ID NO:7), Fusarium osysporum EG (SEQ ID NO:8), Phanerochaete chrysosporium CBH2 (SEQ ID NO:9), Talaromyces emersonii CBH2 (SEQ ID NO:10), Thermobifida.
  • Hypocrea jecorina also known as T. reesei
  • Hypocrea koningii CBH2 SEQ ID NO:4
  • fusca 6B / E3 CBH2 (SEQ ID NO:11), Thermobifida fusca 6A / E2 EG (SEQ ID NO:12), and Cellulomonas fimi CenA EG (SEQ ID NO:13).
  • FIG. 4 provides a graph of the relative frequency of observed over expected pretreated corn stover (PCS) assay winners of the CBH2 variant SELs as a product of charge change. Decreasing CBH2 charge results in a significantly higher frequency of PCS winners.
  • PCS corn stover
  • FIG. 5 provides a plasmid map of pTTTpyr-cbh2.
  • the present teachings relates to cellulase variants modified to reduce binding to non-cellulosic materials.
  • the cellulase variant has increased cellulolytic activity in the presence of non-cellulosic materials in comparison to the wild type cellulase.
  • the variant cellulase has a decreased net charge (i.e. is more negative) in comparison to the wild type cellulase.
  • the cellulase variants are less positively charged than wild type cellulase.
  • a cellulase is modified by removing one or more positive charges.
  • a cellulase is modified by adding one or more negative charges.
  • a cellulase is modified by removing one or more positive charges and adding one or more negative charges.
  • nucleic acids are written left to right in 5' to 3' orientation; amino acid sequences are written left to right in amino to carboxyl orientation, respectively.
  • Practitioners are particularly directed to Sambrook et al., MOLECULAR CLONING: A LABORATORY MANUAL (Second Edition), Cold Spring Harbor Press, Plainview, N.Y., 1989 , and Ausubel FM et al., Current Protocols in Molecular Biology, John Wiley & Sons, New York, N.Y., 1993 , for definitions and terms of the art. It is to be understood that this disclosure is not limited to the particular methodology, protocols, and reagents described, as these may vary.
  • polypeptide refers to a compound made up of a single chain of amino acid residues linked by peptide bonds.
  • protein as used herein may be synonymous with the term “polypeptide”.
  • Variant means a protein which is derived from a precursor protein (e.g., the native protein) by addition of one or more amino acids to either or both the C- and N-terminal end, substitution of one or more amino acids at one or a number of different sites in the amino acid sequence, or deletion of one or more amino acids at either or both ends of the protein or at one or more sites in the amino acid sequence, or one or more amino acids is modified by changing the charge ( i.e. by removing a positive charge, adding a negative charge, or by both removing a positive charge and adding a negative charge).
  • the preparation of a cellulase variant may be performed by any means know in the art, including chemical modification of amino acids, by modifying a DNA sequence which encodes for the native protein, transformation of the modified DNA sequence into a suitable host, and expression of the modified DNA sequence to form the variant enzyme.
  • the variant cellulase of the disclosure includes peptides comprising altered amino acid sequences in comparison with a precursor enzyme amino acid sequence wherein the variant cellulase retains the characteristic cellulolytic nature of the precursor enzyme but which may have altered properties in some specific aspect.
  • a variant cellulase may have an increased pH optimum or increased temperature or oxidative stability or decreased affinity or binding to non-cellulosic materials but will retain its characteristic cellulolytic activity.
  • variants according to the present disclosure may be derived from a DNA fragment encoding a cellulase variant wherein the functional activity of the expressed cellulase variant is retained.
  • a DNA fragment encoding a cellulase may further include a DNA sequence or portion thereof encoding a hinge or linker attached to the cellulase DNA sequence at either the 5' or 3' end wherein the functional activity of the encoded cellulase domain is retained.
  • variant and derivative may be used interchangeably herein.
  • Equivalent residues may also be defined by determining homology at the level of tertiary structure for a precursor cellulase whose tertiary structure has been determined by x-ray crystallography. Equivalent residues are defined as those for which the atomic coordinates of two or more of the main chain atoms of a particular amino acid residue of a cellulase and Hypocrea jecorina CBH2 (N on N, CA on CA, C on C and O on O) are within 0.13 nm and preferably 0.1 nm after alignment. Alignment is achieved after the best model has been oriented and positioned to give the maximum overlap of atomic coordinates of non-hydrogen protein atoms of the cellulase in question to the H. jecorina CBH2. The best model is the crystallographic model giving the lowest R factor for experimental diffraction data at the highest resolution available see for examples US 2006/0205042 .
  • Equivalent residues which are functionally analogous to a specific residue of H. jecorina CBH2 are defined as those amino acids of a cellulase which may adopt a conformation such that they either alter, modify or contribute to protein structure, substrate binding or catalysis in a manner defined and attributed to a specific residue of the H. jecorina CBH2.
  • nucleic acid molecule includes RNA, DNA and cDNA molecules. It will be understood that, as a result of the degeneracy of the genetic code, a multitude of nucleotide sequences encoding a given protein such as CBH2 and/or variants thereof may be produced. The present disclosure contemplates every possible variant nucleotide sequence, encoding variant cellulase such as CBH2, all of which are possible given the degeneracy of the genetic code.
  • a “heterologous” nucleic acid construct or sequence has a portion of the sequence which is not native to the cell in which it is expressed.
  • Heterologous, with respect to a control sequence refers to a control sequence (i.e. promoter or enhancer) that does not function in nature to regulate the same gene the expression of which it is currently regulating.
  • heterologous nucleic acid sequences are not endogenous to the cell or part of the genome in which they are present, and have been added to the cell, by infection, transfection, transformation, microinjection, electroporation, or the like.
  • a “heterologous” nucleic acid construct may contain a control sequence/DNA coding sequence combination that is the same as, or different from a control sequence/DNA coding sequence combination found in the native cell.
  • vector refers to a nucleic acid construct designed for transfer between different host cells.
  • expression vector refers to a vector that has the ability to incorporate and express heterologous DNA fragments in a foreign cell. Many prokaryotic and eukaryotic expression vectors are commercially available. Selection of appropriate expression vectors is within the knowledge of those having skill in the art.
  • an "expression cassette” or “expression vector” is a nucleic acid construct generated recombinantly or synthetically, with a series of specified nucleic acid elements that permit transcription of a particular nucleic acid in a target cell.
  • the recombinant expression cassette can be incorporated into a plasmid, chromosome, mitochondrial DNA, plastid DNA, virus, or nucleic acid fragment.
  • the recombinant expression cassette portion of an expression vector includes, among other sequences, a nucleic acid sequence to be transcribed and a promoter.
  • plasmid refers to a circular double-stranded (ds) DNA construct used as a cloning vector, and which forms an extrachromosomal self-replicating genetic element in many bacteria and some eukaryotes.
  • selectable marker-encoding nucleotide sequence refers to a nucleotide sequence which is capable of expression in cells and where expression of the selectable marker confers to cells containing the expressed gene the ability to grow in the presence of a corresponding selective agent, or under corresponding selective growth conditions.
  • promoter refers to a nucleic acid sequence that functions to direct transcription of a downstream gene.
  • the promoter will generally be appropriate to the host cell in which the target gene is being expressed.
  • the promoter together with other transcriptional and translational regulatory nucleic acid sequences are necessary to express a given gene.
  • control sequences also termed “control sequences”
  • the transcriptional and translational regulatory sequences include, but are not limited to, promoter sequences, ribosomal binding sites, transcriptional start and stop sequences, translational start and stop sequences, and enhancer or activator sequences.
  • Chimeric gene or “heterologous nucleic acid construct”, as defined herein refers to a non-native gene (i.e., one that has been introduced into a host) that may be composed of parts of different genes, including regulatory elements.
  • a chimeric gene construct for transformation of a host cell is typically composed of a transcriptional regulatory region (promoter) operably linked to a heterologous protein coding sequence, or, in a selectable marker chimeric gene, to a selectable marker gene encoding a protein conferring, for example, antibiotic resistance to transformed cells.
  • a typical chimeric gene of the present disclosure, for transformation into a host cell includes a transcriptional regulatory region that is constitutive or inducible, a protein coding sequence, and a terminator sequence.
  • a chimeric gene construct may also include a second DNA sequence encoding a signal peptide if secretion of the target protein is desired.
  • a nucleic acid is "operably linked" when it is placed into a functional relationship with another nucleic acid sequence.
  • DNA encoding a secretory leader is operably linked to DNA for a polypeptide if it is expressed as a preprotein that participates in the secretion of the polypeptide;
  • a promoter or enhancer is operably linked to a coding sequence if it affects the transcription of the sequence; or
  • a ribosome binding site is operably linked to a coding sequence if it is positioned so as to facilitate translation.
  • "operably linked” means that the DNA sequences being linked are contiguous, and, in the case of a secretory leader, contiguous and in reading frame.
  • enhancers do not have to be contiguous. Linking is accomplished by ligation at convenient restriction sites. If such sites do not exist, the synthetic oligonucleotide adaptors, linkers or primers for PCR are used in accordance with conventional practice.
  • the term "gene” means the segment of DNA involved in producing a polypeptide chain, that may or may not include regions preceding and following the coding region, e.g. 5' untranslated (5' UTR) or “leader” sequences and 3' UTR or “trailer” sequences, as well as intervening sequences (introns) between individual coding segments (exons).
  • 5' UTR 5' untranslated
  • leader leader
  • 3' UTR or “trailer” sequences as well as intervening sequences (introns) between individual coding segments (exons).
  • nucleic acid molecules which encode the variant cellulase such as CBH2 will hybridize, under moderate to high stringency conditions to the wild type sequence such as provided herein as SEQ ID NO:1.
  • a CBH2-encoding nucleotide sequence is employed that possesses a substantially different codon usage, while the protein encoded by the CBH2-encoding nucleotide sequence has the same or substantially the same amino acid sequence as the native protein.
  • the coding sequence may be modified to facilitate faster expression of CBH2 in a particular prokaryotic or eukaryotic expression system, in accordance with the frequency with which a particular codon is utilized by the host ( Te'o et al., FEMS Microbiology Letters, 190: 13-19, 2000 , for example, describes the optimization of genes for expression in filamentous fungi).
  • a nucleic acid sequence is considered to be "selectively hybridizable" to a reference nucleic acid sequence if the two sequences specifically hybridize to one another under moderate to high stringency hybridization and wash conditions.
  • Hybridization conditions are based on the melting temperature (T m ) of the nucleic acid binding complex or probe.
  • T m melting temperature
  • “maximum stringency” typically occurs at about T m -5°C(5° C below the T m of the probe); “high stringency” at about 5-10° C below the T m ; “moderate” or “intermediate stringency” at about 10-20° C. below the Tm of the probe; and “low stringency” at about 20-25° Cbelow the T m .
  • maximum stringency conditions may be used to identify sequences having strict identity or near-strict identity with the hybridization probe; while high stringency conditions are used to identify sequences having about 80% or more sequence identity with the probe.
  • Moderate and high stringency hybridization conditions are well known in the art (see, for example, Sambrook, et al, 1989, Chapters 9 and 11, and in Ausubel, F. M., et al., 1993, expressly incorporated by reference herein).
  • An example of high stringency conditions includes hybridization at about 42°C in 50% formamide, 5xSSC, 5timesDenhardt's solution, 0.5% SDS and 100 ug/ml denatured carrier DNA followed by washing two times in 2timesSSC and 0.5% SDS at room temperature and two additional times in 0.1x SSC and 0.5% SDS at 42° degreeC.
  • recombinant when used with reference, e.g., to a cell, or nucleic acid, protein, or vector, indicates that the cell, nucleic acid, protein or vector, has been modified by the introduction of a heterologous nucleic acid or protein or the alteration of a native nucleic acid or protein, or that the cell is derived from a cell so modified.
  • recombinant cells express genes that are not found within the native (non-recombinant) form of the cell or express native genes that are otherwise abnormally expressed, under expressed or not expressed at all.
  • the terms “transformed”, “stably transformed” or “transgenic” with reference to a cell means the cell has a non-native (heterologous) nucleic acid sequence integrated into its genome or as an episomal plasmid that is maintained through multiple generations.
  • expression refers to the process by which a polypeptide is produced based on the nucleic acid sequence of a gene.
  • the process includes both transcription and translation.
  • the term "introduced” in the context of inserting a nucleic acid sequence into a cell means “transfection”, or “transformation” or “transduction” and includes reference to the incorporation of a nucleic acid sequence into a eukaryotic or prokaryotic cell where the nucleic acid sequence may be incorporated into the genome of the cell (for example, chromosome, plasmid, plastid, or mitochondrial DNA), converted into an autonomous replicon, or transiently expressed (for example, transfected mRNA).
  • CBH2 expression refers to transcription and translation of the cbh2 gene or variants thereof, the products of which include precursor RNA, mRNA, polypeptide, post-translationally processed polypeptides, and derivatives thereof, including CBH2 from related species such as Trichoderma koningii, Hypocrea jecorina (also known as Trichoderma longibrachiatum, Trichoderma reesei or Trichoderma viride ) and Hypocrea schweinitzii.
  • assays for CBH2 expression include Western blot for CBH2 protein, Northern blot analysis and reverse transcriptase polymerase chain reaction (RT-PCR) assays for cbh2 mRNA, and Phosphoric Acid Swollen Cellulose (PASC) and p-hydroxybenzoic acid hydrazide (PAHBAH) assays as described in the following: (a) PASC: ( Karlsson, J. et al. (2001), Eur. J. Biochem, 268, 6498-6507 , Wood, T. (1988) in Methods in Enzymology, Vol.160. Biomass Part a Cellulose and Hemicellulose (Wood, W. & Kellog, S.
  • PASC Phosphoric Acid Swollen Cellulose
  • PAHBAH p-hydroxybenzoic acid hydrazide
  • PAHBAH ( Lever, M. (1972) Analytical Biochemistry, 47, 273 , Blakeney, A. B. & Mutton, L. L. (1980) Journal of Science of Food and Agriculture, 31, 889 , Henry, R. J. (1984) Journal of the Institute of Brewing, 90, 37 ).
  • alternative splicing refers to the process whereby multiple polypeptide isoforms are generated from a single gene, and involves the splicing together of nonconsecutive exons during the processing of some, but not all, transcripts of the gene. Thus a particular exon may be connected to any one of several alternative exons to form messenger RNAs.
  • the alternatively-spliced mRNAs produce polypeptides ("splice variants") in which some parts are common while other parts are different.
  • signal sequence refers to a sequence of amino acids at the N-terminal portion of a protein that facilitates the secretion of the mature form of the protein outside the cell.
  • the mature form of the extracellular protein lacks the signal sequence that is cleaved off during the secretion process.
  • host cell By the term “host cell” is meant a cell that contains a vector and supports the replication, and/or transcription or transcription and translation (expression) of the expression construct.
  • Host cells for use in the present disclosure can be prokaryotic cells, such as E. coli, or eukaryotic cells such as yeast, plant, insect, amphibian, or mammalian cells. In general, host cells are filamentous fungi.
  • filamentous fungi means any and all filamentous fungi recognized by those of skill in the art.
  • a preferred fungus is selected from the group consisting of Aspergillus, Trichoderma, Fusarium, Chrysosporium, Penicillium, Humicola, Neurospora, or alternative sexual forms thereof such as Emericella, Hypocrea. It has now been demonstrated that the asexual industrial fungus Trichoderma reesei is a clonal derivative of the ascomycete Hypocrea jecorina (See, Kuhls et al., PNAS, 93:7755-7760, 1996 ).
  • cellooligosaccharide refers to oligosaccharide groups containing from 2-8 glucose units and having beta-1,4 linkages, e.g., cellobiose.
  • cellulase “cellulolytic enzymes” or “cellulase enzymes” refer to a category of enzymes capable of hydrolyzing cellulose polymers to shorter cellooligosaccharide oligomers, cellobiose and/or glucose.
  • cellulases such as exoglucanases, exocellobiohydrolases, endoglucanases, and glucosidases have been obtained from cellulolytic organisms, particularly including fungi, plants and bacteria.
  • the enzymes made by these microbes are mixtures of proteins with three types of actions useful in the conversion of cellulose to glucose: endoglucanases (EG), cellobiohydrolases (CBH), and beta-glucosidase (BGL or Bglu). These three different types of cellulase enzymes act synergistically to convert cellulose and its derivatives to glucose.
  • microbes make enzymes that hydrolyze cellulose, including the wood rotting fungus Trichoderma, the compost bacteria Thermomonospora, Bacillus, and Cellulomonas; Streptomyces; and the fungi Humicola, Aspergillus and Fusarium.
  • CBH2 from Hypocrea jecorina is a member of the Glycosyl Hydrolase Family 6 (hence Cel6) and, specifically, was the first member of that family identified in Hypocrea jecorina (hence Ce16A).
  • the Glycosyl Hydrolase Family 6 contains both Endoglucanases and Cellobiohydrolases/exoglucanases, and that CBH2 is the latter.
  • the phrases CBH2, CBH2-type protein and Cel6 cellobiohydrolases may be used interchangeably herein.
  • cellulose binding domain refers to portion of the amino acid sequence of a cellulase or a region of the enzyme that is involved in the cellulose binding activity of a cellulase or derivative thereof.
  • Cellulose binding domains generally function by non-covalently binding the cellulase to cellulose, a cellulose derivative or other polysaccharide equivalent thereof.
  • Cellulose binding domains permit or facilitate hydrolysis of cellulose fibers by the structurally distinct catalytic core region, and typically function independent of the catalytic core. Thus, a cellulose binding domain will not possess the significant hydrolytic activity attributable to a catalytic core.
  • a cellulose binding domain is a structural element of the cellulase enzyme protein tertiary structure that is distinct from the structural element which possesses catalytic activity.
  • Cellulose binding domain and cellulose binding module may be used interchangeably herein.
  • surfactant refers to any compound generally recognized in the art as having surface active qualities.
  • surfactants comprise anionic, cationic and nonionic surfactants such as those commonly found in detergents.
  • Anionic surfactants include linear or branched alkylbenzenesulfonates; alkyl or alkenyl ether sulfates having linear or branched alkyl groups or alkenyl groups; alkyl or alkenyl sulfates; olefinsulfonates; and alkanesulfonates.
  • Ampholytic surfactants include quaternary ammonium salt sulfonates, and betaine-type ampholytic surfactants.
  • Nonionic surfactants have both the positive and negative charged groups in the same molecule.
  • Nonionic surfactants may comprise polyoxyalkylene ethers, as well as higher fatty acid alkanolamides or alkylene oxide adduct thereof, fatty acid glycerine monoesters, and the like.
  • cellulose containing fabric refers to any sewn or unsewn fabrics, yarns or fibers made of cotton or non-cotton containing cellulose or cotton or non-cotton containing cellulose blends including natural cellulosics and manmade cellulosics (such as jute, flax, ramie, rayon, and lyocell).
  • cotton-containing fabric refers to sewn or unsewn fabrics, yarns or fibers made of pure cotton or cotton blends including cotton woven fabrics, cotton knits, cotton denims, cotton yarns, raw cotton and the like.
  • stonewashing composition refers to a formulation for use in stonewashing cellulose containing fabrics. Stonewashing compositions are used to modify cellulose containing fabrics prior to sale, i.e., during the manufacturing process. In contrast, detergent compositions are intended for the cleaning of soiled garments and are not used during the manufacturing process.
  • detergent composition refers to a mixture which is intended for use in a wash medium for the laundering of soiled cellulose containing fabrics.
  • such compositions may include, in addition to cellulases and surfactants, additional hydrolytic enzymes, builders, bleaching agents, bleach activators, bluing agents and fluorescent dyes, caking inhibitors, masking agents, cellulase activators, antioxidants, and solubilizers.
  • the term "decrease or elimination in expression of the cbh2 gene” means that either that the cbh2 gene has been deleted from the genome and therefore cannot be expressed by the recombinant host microorganism; or that the cbh2 gene or transcript has been modified such that a functional CBH2 enzyme is not produced by the host microorganism or at levels that are significantly less than the unmodified cbh2 gene or transcript.
  • variant cbh2 gene means that the nucleic acid sequence of the cbh2 gene from H. jecorina has been altered by removing, adding, and/or manipulating the coding sequence.
  • purifying generally refers to subjecting transgenic nucleic acid or protein containing cells to biochemical purification and/or column chromatography.
  • the terms “active” and “biologically active” refer to a biological activity associated with a particular protein and are used interchangeably herein.
  • the enzymatic activity associated with a protease is proteolysis and, thus, an active protease has proteolytic activity. It follows that the biological activity of a given protein refers to any biological activity typically attributed to that protein by those of skill in the art.
  • the term "enriched" means that the cellulase such as CBH2 is found in a concentration that is greater relative to the CBH2 concentration found in a wild-type, or naturally occurring, fungal cellulase composition.
  • the terms enriched, elevated and enhanced may be used interchangeably herein.
  • a wild type fungal cellulase composition is one produced by a naturally occurring fungal source and which comprises one or more BGL, CBH and EG components wherein each of these components is found at the ratio produced by the fungal source.
  • an enriched CBH composition would have CBH at an altered ratio wherein the ratio of CBH to other cellulase components (i.e., EGs, beta-glucosidases and other endoglucanases) is elevated. This ratio may be increased by either increasing CBH or decreasing (or eliminating) at least one other component by any means known in the art.
  • isolated or “purified” as used herein refers to a nucleic acid or amino acid that is removed from at least one component with which it is naturally associated.
  • a naturally occurring cellulase system may be purified into substantially pure components by recognized separation techniques well published in the literature, including ion exchange chromatography at a suitable pH, affinity chromatography, size exclusion and the like.
  • ion exchange chromatography usually anion exchange chromatography
  • the purified CBH may then be added to the enzymatic solution resulting in an enriched CBH solution. It is also possible to elevate the amount of CBH produced by a microbe using molecular genetics methods to overexpress the gene encoding CBH, possibly in conjunction with deletion of one or more genes encoding other cellulases.
  • Fungal cellulases may contain more than one CBH component.
  • the different components generally have different isoelectric points which allow for their separation via ion exchange chromatography and the like. Either a single CBH component or a combination of CBH components may be employed in an enzymatic solution.
  • the homolog or variant CBH2 component When employed in enzymatic solutions, the homolog or variant CBH2 component is generally added in an amount sufficient to allow the highest rate of release of soluble sugars from the biomass.
  • the amount of homolog or variant CBH2 component added depends, upon the type of biomass to be saccharified, which can be readily determined by the skilled artisan when employed, the weight percent of the homolog or variant CBH2 component present in the cellulase composition is from preferably between 1 and 100 with illustrative examples being about 1, preferably about 5, preferably about 10, preferably about 15, or preferably about 20 weight percent to preferably about 25, preferably about 30, preferably about 35, preferably about 40, preferably about 45 or preferably about 50 weight percent.
  • preferred ranges may be about 0.5 to about 15 weight percent, about 0.5 to about 20 weight percent, from about 1 to about 10 weight percent, from about 1 to about 15 weight percent, from about 1 to about 20 weight percent, from about 1 to about 25 weight percent, from about 5 to about 20 weight percent, from about 5 to about 25 weight percent, from about 5 to about 30 weight percent, from about 5 to about 35 weight percent, from about 5 to about 40 weight percent, from about 5 to about 45 weight percent, from about 5 to about 50 weight percent, from about 10 to about 20 weight percent, from about 10 to about 25 weight percent, from about 10 to about 30 weight percent, from about 10 to about 35 weight percent, from about 10 to about 40 weight percent, from about 10 to about 45 weight percent, from about 10 to about 50 weight percent, from about 15 to about 60 weight percent, from about 15 to about 65 weight percent, from about 15 to about 70 weight percent, from about 15 to about 75 weight percent, from about 15 to about 80 weight percent, from about 15 to about 85 weight percent, from about 15 to about 95 weight percent.
  • the weight percent of the homolog or variant CBH2 component relative to any EG type components present in the cellulase composition is from preferably about 1, preferably about 5, preferably about 10, preferably about 15, or preferably about 20 weight percent to preferably about 25, preferably about 30, preferably about 35, preferably about 40, preferably about 45 or preferably about 50 weight percent.
  • preferred ranges may be about 0.5 to about 15 weight percent, about 0.5 to about 20 weight percent, from about 1 to about 10 weight percent, from about 1 to about 15 weight percent, from about 1 to about 20 weight percent, from about 1 to about 25 weight percent, from about 5 to about 20 weight percent, from about 5 to about 25 weight percent, from about 5 to about 30 weight percent, from about 5 to about 35 weight percent, from about 5 to about 40 weight percent, from about 5 to about 45 weight percent, from about 5 to about 50 weight percent, from about 10 to about 20 weight percent, from about 10 to about 25 weight percent, from about 10 to about 30 weight percent, from about 10 to about 35 weight percent, from about 10 to about 40 weight percent, from about 10 to about 45 weight percent, from about 10 to about 50 weight percent, from about 15 to about 20 weight percent, from about 15 to about 25 weight percent, from about 15 to about 30 weight percent, from about 15 to about 35 weight percent, from about 15 to about 30 weight percent, from about 15 to about 45 weight percent, from about 15 to about 50 weight percent.
  • Cellulases are known in the art as enzymes that hydrolyze cellulose (beta-1,4-glucan or beta D-glucosidic linkages) resulting in the formation of glucose, cellobiose, cellooligosaccharides, and the like. As set forth above, cellulases have been traditionally divided into three major classes: endoglucanases (EC 3.2.1.4) (“EG”), exoglucanases or cellobiohydrolases (EC 3.2.1.91) (“CBH”) and beta-glucosidases (EC 3.2.1.21) (“BG”).
  • EG endoglucanases
  • CBH cellobiohydrolases
  • BG beta-glucosidases
  • Certain fungi produce complete cellulase systems which include exo-cellobiohydrolases or CBH-type cellulases, endoglucanases or EG-type cellulases and beta-glucosidases or BG-type cellulases.
  • CBH-type cellulases endoglucanases
  • EG-type cellulases endoglucanases
  • beta-glucosidases or BG-type cellulases.
  • the different components i.e., the various endoglucanases and exocellobiohydrolases in a multi-component or complete cellulase system, generally have different properties, such as isoelectric point, molecular weight, degree of glycosylation, substrate specificity and enzymatic action patterns.
  • endoglucanase-type cellulases hydrolyze internal beta-1,4-glucosidic bonds in regions of low crystallinity of the cellulose and exo-cellobiohydrolase-type cellulases hydrolyze cellobiose from the reducing or non-reducing end of cellulose. It follows that the action of endoglucanase components can greatly facilitate the action of exo-cellobiohydrolases by creating new chain ends which are recognized by exo-cellobiohydrolase components.
  • beta-glucosidase-type cellulases have been shown to catalyze the hydrolysis of alkyl and/or aryl .beta.-D-glucosides such as methyl .beta.-D-glucoside and p-nitrophenyl glucoside as well as glycosides containing only carbohydrate residues, such as cellobiose. This yields glucose as the sole product for the microorganism and reduces or eliminates cellobiose which inhibits cellobiohydrolases and endoglucanases.
  • Cellulases also find a number of uses in detergent compositions including to enhance cleaning ability, as a softening agent and to improve the feel of cotton fabrics ( Hemmpel, ITB Dyeing/Printing/Finishing 3:5-14, 1991 ; Tyndall, Textile Chemist and Colorist 24:23-26, 1992 ; and Kumar et al., Textile Chemist and Colorist, 29:37-42, 1997 ). While the mechanism is not part of the disclosure, softening and color restoration properties of cellulase have been attributed to the alkaline endoglucanase components in cellulase compositions, as exemplified by U.S. Pat. Nos.
  • Cellulase compositions have also been shown to degrade cotton-containing fabrics, resulting in reduced strength loss in the fabric ( U.S. Pat. No. 4,822,516 ), contributing to reluctance to use cellulase compositions in commercial detergent applications.
  • Cellulase compositions comprising endoglucanase components have been suggested to exhibit reduced strength loss for cotton-containing fabrics as compared to compositions comprising a complete cellulase system.
  • Cellulases have also been shown to be useful in degradation of cellulase biomass to ethanol (wherein the cellulase degrades cellulose to glucose and yeast or other microbes further ferment the glucose into ethanol), in the treatment of mechanical pulp ( Pere et al., In Proc. Tappi Pulping Conf., Nashville, Tenn., 27-31, pp. 693-696, 1996 ), for use as a feed additive ( WO 91/04673 ) and in grain wet milling.
  • CBHs and EGs have a multidomain structure consisting of a core domain separated from a cellulose binding domain (CBD) by a linker peptide (Suurnakki et al., 2000).
  • the core domain contains the active site whereas the CBD interacts with cellulose by binding the enzyme to it ( van Tilbeurgh et al., FEBS Lett. 204:223-227, 1986 ; Tomme et al., Eur. J. Biochem. 170:575-581, 1988 ).
  • the CBDs are particularly important in the hydrolysis of crystalline cellulose. It has been shown that the ability of cellobiohydrolases to degrade crystalline cellulose clearly decreases when the CBD is absent ( Linder and Teeri, J.
  • CBDs enhances the enzymatic activity merely by increasing the effective enzyme concentration at the surface of cellulose ( Stahlberg et al., Bio/Technol. 9:286-290, 1991 ), and/or by loosening single cellulose chains from the cellulose surface ( Tormo et al., EMBO J. vol. 15, no. 21, pp. 5739-5751, 1996 ).
  • compositions for degrading wood pulp or other biomass into sugars e.g., for biochemicals production such as bio-fuels
  • detergent compositions that exhibit enhanced cleaning ability (3)function as a softening agent and/or improve the feel of cotton fabrics e.g., "stone washing” or “biopolishing”
  • feed compositions for example.
  • whole cellulase preparation comprising cellulase variants.
  • whole cellulase preparation refers to both naturally occurring and non-naturally occurring cellulase containing compositions.
  • a "naturally occurring” composition is one produced by a naturally occurring source and which comprises one or more cellobiohydrolase-type, one or more endoglucanase-type, and one or more beta-glucosidase components wherein each of these components is found at the ratio produced by the source.
  • a naturally occurring composition is one that is produced by an organism unmodified with respect to the cellulolytic enzymes such that the ratio of the component enzymes is unaltered from that produced by the native organism.
  • non-naturally occurring composition encompasses those compositions produced by: (1) combining component cellulolytic enzymes either in a naturally occurring ratio or non-naturally occurring, i.e., altered, ratio; or (2) modifying an organism to overexpress or underexpress one or more cellulolytic enzyme; or (3) modifying an organism such that at least one cellulolytic enzyme is deleted.
  • the whole cellulase preparation can have one or more of the various EGs and/or CBHs, and/or beta-glucosidase deleted.
  • EG1 may be deleted alone or in combination with other EGs and/or CBHs.
  • the whole cellulase preparation includes enzymes including, but are not limited to: (i) endoglucanases (EG) or 1,4- ⁇ -d-glucan-4-glucanohydrolases (EC 3.2.1.4), (ii) exoglucanases, including 1,4- ⁇ -d-glucan glucanohydrolases (also known as cellodextrinases) (EC 3.2.1.74) and 1,4- ⁇ -d-glucan cellobiohydrolases (exo-cellobiohydrolases, CBH) (EC 3.2.1.91), and (iii) ⁇ -glucosidase (BG) or ⁇ -glucoside glucohydrolases (EC 3.2.1.21).
  • endoglucanases EG
  • 1,4- ⁇ -d-glucan-4-glucanohydrolases EC 3.2.1.4
  • exoglucanases including 1,4- ⁇ -d-glucan glucanohydrolases (also known as cellodext
  • the whole cellulase preparation can be from any microorganism that is useful for the hydrolysis of a cellulosic material.
  • the whole cellulase preparation is a filamentous fungi whole cellulase. "Filamentous fungi” include all filamentous forms of the subdivision Eumycota and Oomycota.
  • the whole cellulase preparation is a Acremonium, Aspergillus, Emericella, Fusarium, Humicola, Mucor, Myceliophthora, Neurospora, Scytalidium, Thielavia, Tolypocladium, or Trichoderma species, whole cellulase.
  • the whole cellulase preparation is an Aspergillus aculeatus, Aspergillus awamori, Aspergillus foetidus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, or Aspergillus oryzae whole cellulase.
  • whole cellulase preparation is a Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi, Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusarium sporotrichioides, Fusarium sulphureum, Fusarium torulosuzn, Fusarium trichothecioides, or Fusarium venenatum whole cellulase.
  • the whole cellulase preparation is a Humicola insolens, Humicola lanuginosa, Mucor miehei, Myceliophthora thermophila, Neurospora crassa, Scytalidium thermophilum, or Thielavia terrestris whole cellulase.
  • the whole cellulase preparation a Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei e.g., RL-P37 ( Sheir-Neiss et al., Appl. Microbiol. Biotechnology, 20 (1984) pp.
  • the whole cellulase preparation is a Trichoderma reesei RutC30 whole cellulase, which is available from the American Type Culture Collection as Trichoderma reesei ATCC 56765.
  • Examples of commercial cellulase preparations suitable for use in the present disclosure include, for example, CELLUCLAST TM (available from Novozymes A/S) and LAMINEX TM , IndiAge TM and Priinafast TM LAMINEX BG enzyme, ACCELLERASE TM 100 and ACCELLERASE TM 1500 (available Genencor Division, Danisco US. Inc.)
  • the whole cellulase preparation can be from any microorganism cultivation method known in the art resulting in the expression of enzymes capable of hydrolyzing a cellulosic material. Fermentation can include shake flask cultivation, small- or large-scale fermentation, such as continuous, batch, fed-batch, or solid state fermentations in laboratory or industrial fermenters performed in a suitable medium and under conditions allowing the cellulase to be expressed or isolated.
  • the microorganism is cultivated in a cell culture medium suitable for production of enzymes capable of hydrolyzing a cellulosic material.
  • the cultivation takes place in a suitable nutrient medium comprising carbon and nitrogen sources and inorganic salts, using procedures known in the art.
  • suitable culture media, temperature ranges and other conditions suitable for growth and cellulase production are known in the art.
  • the normal temperature range for the production of cellulases by Trichoderma reesei is 24°C to 28°C.
  • the whole cellulase preparation is used as is produced by fermentation with no or minimal recovery and/or purification.
  • the cell culture medium containing the cellulases can be used.
  • the whole cellulase preparation comprises the unfractionated contents of fermentation material, including cell culture medium, extracellular enzymes and cells.
  • the whole cellulase preparation can be processed by any convenient method, e.g., by precipitation, centrifugation, affinity, filtration or any other method known in the art.
  • the whole cellulase preparation can be concentrated, for example, and then used without further purification.
  • the whole cellulase preparation comprises chemical agents that decrease cell viability or kills the cells.
  • the cells are lysed or permeabilized using methods known in the art.
  • this disclosure provides for the expression of variant cbh2 genes under control of a promoter functional in a filamentous fungus. Therefore, this disclosure relies on routine techniques in the field of recombinant genetics (See, e.g., Sambrook et al., Molecular Cloning, A Laboratory Manual, 2nd ed., 1989 ; Kriegler, Gene Transfer and Expression: A Laboratory Manual, 1990 ; and Ausubel et al., eds., CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, Greene Publishing and Wiley-Interscience, New York, 1994 ).
  • the present disclosure relates to the expression, purification and/or isolation and use of variant CBH2.
  • These enzymes are preferably prepared by recombinant methods utilizing the cbh2 gene from H. jecorina.
  • the fermentation broth may be used with or without purification.
  • DNA encoding an amino acid sequence variant of the H. jecorina CBH2 is prepared by a variety of methods known in the art. These methods include, but are not limited to, preparation by site-directed (or oligonucleotide-mediated) mutagenesis, PCR mutagenesis, and cassette mutagenesis of an earlier prepared DNA encoding the H. jecorina CBH2.
  • Site-directed mutagenesis is a preferred method for preparing substitution variants. This technique is well known in the art (see, e.g., Carter et al. Nucleic Acids Res. 13:4431-4443 (1985 ) and Kunkel et al., Proc. Natl. Acad. Sci. USA 82:488 (1987 )). Briefly, in carrying out site-directed mutagenesis of DNA, the starting DNA is altered by first hybridizing an oligonucleotide encoding the desired mutation to a single strand of such starting DNA.
  • a DNA polymerase is used to synthesize an entire second strand, using the hybridized oligonucleotide as a primer, and using the single strand of the starting DNA as a template.
  • the oligonucleotide encoding the desired mutation is incorporated in the resulting double-stranded DNA.
  • the starting material is the plasmid (or other vector) comprising the starting polypeptide DNA to be mutated.
  • the codon(s) in the starting DNA to be mutated are identified.
  • the plasmid DNA is cut at these sites to linearize it.
  • a double-stranded oligonucleotide encoding the sequence of the DNA between the restriction sites but containing the desired mutation(s) is synthesized using standard procedures, wherein the two strands of the oligonucleotide are synthesized separately and then hybridized together using standard techniques.
  • This double-stranded oligonucleotide is referred to as the cassette.
  • This cassette is designed to have 5' and 3' ends that are compatible with the ends of the linearized plasmid, such that it can be directly ligated to the plasmid.
  • This plasmid now contains the mutated DNA sequence.
  • the desired amino acid sequence encoding a variant CBH2 can be determined, and a nucleic acid sequence encoding such amino acid sequence variant can be generated synthetically.
  • the variant CBH2(s) so prepared may be subjected to further modifications, oftentimes depending on the intended use of the cellulase. Such modifications may involve further alteration of the amino acid sequence, fusion to heterologous polypeptide(s) and/or covalent modifications.
  • the nucleic acid sequence for the wild type cbh2 is shown in SEQ ID NO: 1.
  • the disclosure encompasses a nucleic acid molecule encoding the variant cellulases described herein.
  • the nucleic acid may be a DNA molecule.
  • a preferred mode for preparing variant CBH2 cellulases according to the present disclosure comprises transforming a Trichoderma sp. host cell with a DNA construct comprising at least a fragment of DNA encoding a portion or all of the variant CBH2.
  • the DNA construct will generally be functionally attached to a promoter.
  • the transformed host cell is then grown under conditions so as to express the desired protein. Subsequently, the desired protein product may be purified to substantial homogeneity.
  • the best expression vehicle for a given DNA encoding a variant CBH2 may differ from H. jecorina.
  • Aspergillus niger can be used as an expression vehicle.
  • transformation techniques with A. niger see WO 98/31821 , the disclosure of which is incorporated by reference in its entirety.
  • an Aspergillus spp. expression system is provided for illustrative purposes only and as one option for expressing the variant CBH2 of the disclosure.
  • One of skill in the art may be inclined to express the DNA encoding variant CBH2 in a different host cell if appropriate and it should be understood that the source of the variant CBH2 should be considered in determining the optimal expression host.
  • the skilled worker in the field will be capable of selecting the best expression system for a particular gene through routine techniques utilizing the tools available in the art.
  • the variant CBH2's of this disclosure have amino acid sequences that are derived from the amino acid sequence of a precursor CBH2.
  • the amino acid sequence of the CBH2 variant differs from the precursor CBH2 amino acid sequence by the substitution, deletion or insertion of one or more amino acids of the precursor amino acid sequence.
  • the precursor CBH2 is Hypocrea jecorina CBH2.
  • the mature amino acid sequence of H. jecorina CBH2 is shown in SEQ ID NO:3.
  • this disclosure is directed to CBH2 variants which contain amino acid residues at positions which are equivalent to the particular identified residue in H. jecorina CBH2.
  • a residue (amino acid) of an CBH2 homolog is equivalent to a residue of Hypocrea jecorina CBH2 if it is either homologous (i.e., corresponding in position in either primary or tertiary structure) or is functionally analogous to a specific residue or portion of that residue in Hypocrea jecorina CBH2 (i.e., having the same or similar functional capacity to combine, react, or interact chemically or structurally).
  • numbering is intended to correspond to that of the mature CBH2 amino acid sequence (SEQ ID NO:3).
  • Alignment of amino acid sequences to determine homology is preferably determined by using a "sequence comparison algorithm.”
  • Optimal alignment of sequences for comparison can be conducted, e.g., by the local homology algorithm of Smith & Waterman, Adv. Appl. Math. 2:482 (1981 ), by the homology alignment algorithm of Needleman & Wunsch, J. Mol. Biol. 48:443 (1970 ), by the search for similarity method of Pearson & Lipman, Proc. Nat'l Acad. Sci.
  • HSPs high scoring sequence pairs
  • the word hits are expanded in both directions along each of the two sequences being compared for as far as the cumulative alignment score can be increased. Extension of the word hits is stopped when: the cumulative alignment score falls off by the quantity X from a maximum achieved value; the cumulative score goes to zero or below; or the end of either sequence is reached.
  • the BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment.
  • the BLAST program uses as defaults a word length (W) of 11, the BLOSUM62 scoring matrix (see Henikoff & Henikoff, Proc. Natl. Acad. Sci. USA 89:10915 (1989 )) alignments (B) of 50, expectation (E) of 10, M'5, N'-4, and a comparison of both strands.
  • the BLAST algorithm then performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin & Altschul, Proc. Nat'l. Acad. Sci. USA 90:5873-5787 (1993 )).
  • One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance.
  • P(N) the smallest sum probability
  • an amino acid sequence is considered similar to a protease if the smallest sum probability in a comparison of the test amino acid sequence to a protease amino acid sequence is less than about 0.1, more preferably less than about 0.01, and most preferably less than about 0.001.
  • the degree of identity may be suitably determined by means of computer programs known in the art, such as GAP provided in the GCG program package (Program Manual for the Wisconsin Package, Version 8, August 1994, Genetics Computer Group, 575 Science Drive, Madison, Wis., USA 53711) ( Needleman, S. B. and Wunsch, C. D., (1970), Journal of Molecular Biology, 48, 443-45 ), using GAP with the following settings for polynucleotide sequence comparison: GAP creation penalty of 5.0 and GAP extension penalty of 0.3.
  • a structural alignment between a T. reesei CBH2 and other cellulases may be used to identify equivalent/corresponding positions in other cellulases having a moderate to high degree of homology, e.g., about 50%, 55%, 60 %, 65%, 70%, 75%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or even 99%, with T. reesei CBH2 (SEQ ID NO: 3).
  • One method of obtaining said structural alignment is to use the Pile Up programme from the GCG package using default values of gap penalties, i .
  • the reference cellulases include: Hypocrea jecorina (also known as T . reesei) CBH2 (SEQ ID NO:3), Hypocrea koningii CBH2 (SEQ ID NO:4), Humicola insolens CBH2 (SEQ ID NO:5), Acreemonium cellulolyticus CBH2 (SEQ ID NO:6), Agaricus bisporus CBH2 (SEQ ID NO:7), Fusarium osysporum EG (SEQ ID NO: 8), Phanerochaete chrysosporium CBH2 (SEQ ID NO:9), Talaromyces emersonii CBH2 (SEQ ID NO: 10), Thermobifida.
  • Hypocrea jecorina also known as T . reesei
  • Hypocrea koningii CBH2 SEQ ID NO:4
  • Humicola insolens CBH2 SEQ ID NO:5
  • Sequence searches are typically carried out using the BLASTN program when evaluating a given nucleic acid sequence relative to nucleic acid sequences in the GenBank DNA Sequences and other public databases.
  • the BLASTX program is preferred for searching nucleic acid sequences that have been translated in all reading frames against amino acid sequences in the GenBank Protein Sequences and other public databases. Both BLASTN and BLASTX are run using default parameters of an open gap penalty of 11.0, and an extended gap penalty of 1.0, and utilize the BLOSUM-62 matrix. (See, e.g., Altschul, et al., 1997.)
  • the methods of the disclosure rely on the use cells to express variant CBH2, with no particular method of CBH2 expression required.
  • the variant CBH2 is preferably secreted from the cells.
  • the disclosure provides host cells which have been transduced, transformed or transfected with an expression vector comprising a variant CBH2-encoding nucleic acid sequence.
  • the culture conditions such as temperature, pH and the like, are those previously used for the parental host cell prior to transduction, transformation or transfection and will be apparent to those skilled in the art.
  • a filamentous fungal cell or yeast cell is transfected with an expression vector having a promoter or biologically active promoter fragment or one or more (e.g., a series) of enhancers which functions in the host cell line, operably linked to a DNA segment encoding variant CBH2, such that variant CBH2 is expressed in the cell line.
  • Natural or synthetic polynucleotide fragments encoding variant CBH2 may be incorporated into heterologous nucleic acid constructs or vectors, capable of introduction into, and replication in, a filamentous fungal or yeast cell.
  • the vectors and methods disclosed herein are suitable for use in host cells for the expression of variant CBH2. Any vector may be used as long as it is replicable and viable in the cells into which it is introduced. Large numbers of suitable vectors and promoters are known to those of skill in the art, and are commercially available.
  • Cloning and expression vectors are also described in Sambrook et al., 1989, Ausubel F M et al., 1989, and Strathern et al., The Molecular Biology of the Yeast Saccharomyces, 1981 , each of which is expressly incorporated by reference herein.
  • Appropriate expression vectors for fungi are described in van den Hondel, C. A. M. J. J. et al. (1991) In: Bennett, J. W. and Lasure, L. L. (eds.) More Gene Manipulations in Fungi. Academic Press, pp. 396-428 .
  • the appropriate DNA sequence may be inserted into a plasmid or vector (collectively referred to herein as "vectors") by a variety of procedures.
  • vectors a plasmid or vector
  • the DNA sequence is inserted into an appropriate restriction endonuclease site(s) by standard procedures.
  • procedures and related sub-cloning procedures are deemed to be within the scope of knowledge of those skilled in the art.
  • Recombinant filamentous fungi comprising the coding sequence for variant CBH2 may be produced by introducing a heterologous nucleic acid construct comprising the variant CBH2 coding sequence into the cells of a selected strain of the filamentous fungi.
  • flanking regions may be subjected to resection, mutagenesis, etc.
  • transitions, transversions, deletions, and insertions may be performed on the naturally occurring sequence.
  • a selected variant cbh2 coding sequence may be inserted into a suitable vector according to well-known recombinant techniques and used to transform filamentous fungi capable of CBH2 expression. Due to the inherent degeneracy of the genetic code, other nucleic acid sequences which encode substantially the same or a functionally equivalent amino acid sequence may be used to clone and express variant CBH2. Therefore it is appreciated that such substitutions in the coding region fall within the sequence variants covered by the present disclosure. Any and all of these sequence variants can be utilized in the same way as described herein for a parent CBH2-encoding nucleic acid sequence.
  • the present disclosure also includes recombinant nucleic acid constructs comprising one or more of the variant CBH2-encoding nucleic acid sequences as described above.
  • the constructs comprise a vector, such as a plasmid or viral vector, into which a sequence of the disclosure has been inserted, in a forward or reverse orientation.
  • Heterologous nucleic acid constructs may include the coding sequence for variant cbh2. (i) in isolation; (ii) in combination with additional coding sequences; such as fusion protein or signal peptide coding sequences, where the cbh2 coding sequence is the dominant coding sequence; (iii) in combination with non-coding sequences, such as introns and control elements, such as promoter and terminator elements or 5' and/or 3' untranslated regions, effective for expression of the coding sequence in a suitable host; and/or (iv) in a vector or host environment in which the cbh2 coding sequence is a heterologous gene.
  • a heterologous nucleic acid construct is employed to transfer a variant CBH2-encoding nucleic acid sequence into a cell in vitro, with established filamentous fungal and yeast lines preferred.
  • stable expression is preferred. It follows that any method effective to generate stable transformants may be used in practicing the disclosure.
  • Appropriate vectors are typically equipped with a selectable marker-encoding nucleic acid sequence, insertion sites, and suitable control elements, such as promoter and termination sequences.
  • the vector may comprise regulatory sequences, including, for example, non-coding sequences, such as introns and control elements, i.e., promoter and terminator elements or 5' and/or 3' untranslated regions, effective for expression of the coding sequence in host cells (and/or in a vector or host cell environment in which a modified soluble protein antigen coding sequence is not normally expressed), operably linked to the coding sequence.
  • suitable vectors and promoters are known to those of skill in the art, many of which are commercially available and/or are described in Sambrook, et al., (supra).
  • Exemplary promoters include both constitutive promoters and inducible promoters, examples of which include a CMV promoter, an SV40 early promoter, an RSV promoter, an EF-1.alpha. promoter, a promoter containing the tet responsive element (TRE) in the tet-on or tet-off system as described (ClonTech and BASF), the beta actin promoter and the metallothionine promoter that can upregulated by addition of certain metal salts.
  • a promoter sequence is a DNA sequence which is recognized by the particular filamentous fungus for expression purposes. It is operably linked to DNA sequence encoding a variant CBH2 polypeptide.
  • Such linkage comprises positioning of the promoter with respect to the initiation codon of the DNA sequence encoding the variant CBH2 polypeptide in the disclosed expression vectors.
  • the promoter sequence contains transcription and translation control sequence which mediate the expression of the variant CBH2 polypeptide. Examples include the promoters from the Aspergillus niger, A awamori or A. oryzae glucoamylase, alpha-amylase, or alpha-glucosidase encoding genes; the A. nidulans gpdA or trpC Genes; the Neurospora crassa cbh1 or trp1 genes; the A.
  • H. jecorina T. reesei
  • cbh1, cbh2, egl1, egl2, or other cellulase encoding genes the H. jecorina (T. reesei) cbh1, cbh2, egl1, egl2, or other cellulase encoding genes.
  • selectable marker genes include argB from A . nidulans or T. reesei, amdS from A . nidulans, pyr4 from Neurospora crassa or T. reesei, pyrG from Aspergillus niger or A . nidulans.
  • Additional exemplary selectable markers include, but are not limited to trpc, trp1, oliC31, niaD or leu2, which are included in heterologous nucleic acid constructs used to transform a mutant strain such as trp-, pyr-, leu- and the like.
  • selectable markers confer to transformants the ability to utilize a metabolite that is usually not metabolized by the filamentous fungi.
  • the amdS gene from H. jecorina which encodes the enzyme acetamidase that allows transformant cells to grow on acetamide as a nitrogen source.
  • the selectable marker e.g. pyrG
  • the selectable marker coding sequence is cloned into any suitable plasmid using methods generally employed in the art.
  • Exemplary plasmids include pUC18, pBR322, pRAX and pUC100.
  • the pRAX plasmid contains AMAL sequences from A. nidulans, which make it possible to replicate in A. niger.
  • filamentous fungi comprising cells which have been modified, selected and cultured in a manner effective to result in variant CBH2 production or expression relative to the corresponding non-transformed parental fungi.
  • Examples of species of parental filamentous fungi that may be treated and/or modified for variant CBH2 expression include, but are not limited to Trichoderma, e.g., Trichoderma reesei, Trichoderma longibrachiatum, Trichoderma viride, Trichoderma koningii; Penicillium sp., Humicola sp., including Humicola insolens; Aspergillus sp., Chrysosporium sp., Fusarium sp., Hypocrea sp., and Emericella sp.
  • Trichoderma e.g., Trichoderma reesei, Trichoderma longibrachiatum, Trichoderma viride, Trichoderma koningii
  • Penicillium sp. Humicola sp., including Humicola insolens
  • Aspergillus sp. Chrysosporium sp., Fusarium sp., Hypocrea
  • CBH2 expressing cells are cultured under conditions typically employed to culture the parental fungal line.
  • cells are cultured in a standard medium containing physiological salts and nutrients, such as described in Pourquie, J. et al., Biochemistry and Genetics of Cellulose Degradation, eds. Aubert, J. P. et al., Academic Press, pp. 71-86, 1988 and Ilmen, M. et al., Appl. Environ. Microbiol. 63:1298-1306, 1997 .
  • Culture conditions are also standard, e.g., cultures are incubated at 28.degree. C. in shaker cultures or fermenters until desired levels of CBH2 expression are achieved.
  • Preferred culture conditions for a given filamentous fungus may be found in the scientific literature and/or from the source of the fungi such as the American Type Culture Collection (ATCC; www.atcc.org/). After fungal growth has been established, the cells are exposed to conditions effective to cause or permit the expression of variant CBH2.
  • ATCC American Type Culture Collection
  • the inducing agent e.g., a sugar, metal salt or antibiotics
  • the inducing agent is added to the medium at a concentration effective to induce CBH2 expression.
  • the strain comprises Aspergillus niger, which is a useful strain for obtaining overexpressed protein.
  • Aspergillus niger is a useful strain for obtaining overexpressed protein.
  • a . niger var awamori dgr246 is known to secrete elevated amounts of secreted cellulases ( Goedegehuur et al., Curr. Genet (2002) 41: 89-98 ).
  • Other strains of Aspergillus niger var awamori such as GCDAP3, GCDAP4 and GAP3-4 are known ( Ward et al., Appl. Microbiol. Biotechnol. 39:738-743, 1993 ).
  • the strain comprises Trichoderma reesei, which is a useful strain for obtaining overexpressed protein.
  • Trichoderma reesei which is a useful strain for obtaining overexpressed protein.
  • RL-P37 described by Sheir-Neiss, et al., Appl. Microbiol. Biotechnol. 20:46-53 (1984 ) is known to secrete elevated amounts of cellulase enzymes.
  • Functional equivalents of RL-P37 include Trichoderma reesei strain RUT-C30 (ATCC No. 56765) and strain QM9414 (ATCC No. 26921). It is contemplated that these strains would also be useful in overexpressing variant CBH2.
  • Trichoderma host cell strain which has had one or more cellulase genes deleted prior to introduction of a DNA construct or plasmid containing the DNA fragment encoding the variant CBH2.
  • Such strains may be prepared by the method disclosed in U.S. Pat. No. 5,246,853 and WO 92/06209 , which disclosures are hereby incorporated by reference.
  • cbh1, cbh2, egl1, and egl2 genes can be deleted, for example, the cbh1, cbh2, egl1, and egl2 genes as well as those encoding EG III and/or EGV protein (see e.g., U.S. Pat. No. 5,475,101 and WO 94/28117 , respectively).
  • Gene deletion may be accomplished by inserting a form of the desired gene to be deleted or disrupted into a plasmid by methods known in the art.
  • the deletion plasmid is then cut at an appropriate restriction enzyme site(s), internal to the desired gene coding region, and the gene coding sequence or part thereof replaced with a selectable marker. Flanking DNA sequences from the locus of the gene to be deleted or disrupted, preferably between about 0.5 to 2.0 kb, remain on either side of the selectable marker gene.
  • An appropriate deletion plasmid will generally have unique restriction enzyme sites present therein to enable the fragment containing the deleted gene, including flanking DNA sequences, and the selectable marker gene to be removed as a single linear piece.
  • a selectable marker must be chosen so as to enable detection of the transformed microorganism. Any selectable marker gene that is expressed in the selected microorganism will be suitable. For example, with Aspergillus sp., the selectable marker is chosen so that the presence of the selectable marker in the transformants will not significantly affect the properties thereof.
  • a selectable marker may be a gene that encodes an assayable product. For example, a functional copy of a Aspergillus sp. gene may be used which if lacking in the host strain results in the host strain displaying an auxotrophic phenotype. Similarly, selectable markers exist for Trichoderma sp.
  • a pyrG- derivative strain of Aspergillus sp. is transformed with a functional pyrG gene, which thus provides a selectable marker for transformation.
  • a pyrG-derivative strain may be obtained by selection of Aspergillus sp. strains that are resistant to fluoroorotic acid (FOA).
  • the pyrG gene encodes orotidine-5'-monophosphate decarboxylase, an enzyme required for the biosynthesis of uridine. Strains with an intact pyrG gene grow in a medium lacking uridine but are sensitive to fluoroorotic acid.
  • pyrG-derivative strains that lack a functional orotidine monophosphate decarboxylase enzyme and require uridine for growth by selecting for FOA resistance.
  • FOA selection technique it is also possible to obtain uridine-requiring strains which lack a functional orotate pyrophosphoribosyl transferase. It is possible to transform these cells with a functional copy of the gene encoding this enzyme ( Berges & Barreau, Curr. Genet. 19:359-365 (1991 ), and van Hartingsveldt et al., (1986) Development of a homologous transformation system for Aspergillus niger based on the pyrG gene. Mol. Gen. Genet. 206:71-75 ). Selection of derivative strains is easily performed using the FOA resistance technique referred to above, and thus, the pyrG gene is preferably employed as a selectable marker.
  • a pyr4. - derivative strain of Hyprocrea sp. (Hyprocrea sp. (Trichoderma sp.)) is transformed with a functional pyr4 gene, which thus provides a selectable marker for transformation.
  • a pyr4.sup.- derivative strain may be obtained by selection of Hyprocrea sp. (Trichoderma sp.) strains that are resistant to fluoroorotic acid (FOA).
  • the pyr4 gene encodes orotidine-5'-monophosphate decarboxylase, an enzyme required for the biosynthesis of uridine. Strains with an intact pyr4 gene grow in a medium lacking uridine but are sensitive to fluoroorotic acid.
  • a single DNA fragment comprising a disrupted or deleted cellulase gene is then isolated from the deletion plasmid and used to transform an appropriate pyr- Aspergillus or pyr- Trichoderma host.
  • Transformants are then identified and selected based on their ability to express the pyrG or pyr4, respectively, gene product and thus compliment the uridine auxotrophy of the host strain.
  • Southern blot analysis is then carried out on the resultant transformants to identify and confirm a double crossover integration event that replaces part or all of the coding region of the genomic copy of the gene to be deleted with the appropriate pyr selectable markers.
  • the present disclosure is not limited to these vectors.
  • Various genes can be deleted and replaced in the Aspergillus sp. or Hyprocrea sp. (Trichoderma sp.) strain using the above techniques.
  • any available selectable markers can be used, as discussed above.
  • any host e.g., Aspergillus sp. or Hyprocrea sp., gene that has been cloned, and thus identified, can be deleted from the genome using the above-described strategy.
  • the host strains used may be derivatives of Hyprocrea sp. (Trichoderma sp.) that lack or have a nonfunctional gene or genes corresponding to the selectable marker chosen.
  • the selectable marker of pyrG is chosen for Aspergillus sp.
  • a specific pyrG- derivative strain is used as a recipient in the transformation procedure.
  • selectable marker of pyr4 is chosen for a Hyprocrea sp.
  • a specific pyr4- derivative strain is used as a recipient in the transformation procedure.
  • Trichoderma sp. genes equivalent to the Aspergillus nidulans genes amdS, argB, trpC, niaD may be used.
  • the corresponding recipient strain must therefore be a derivative strain such as argB-, trpC-, niaD-, respectively.
  • DNA encoding the CBH2 variant is then prepared for insertion into an appropriate microorganism.
  • DNA encoding a CBH2 variant comprises the DNA necessary to encode for a protein that has functional cellulolytic activity.
  • the DNA fragment encoding the CBH2 variant may be functionally attached to a fungal promoter sequence, for example, the promoter of the glaA gene in Aspergillus or the promoter of the cbh1 or egl1 genes in Trichoderma.
  • DNA encoding the CBH2 variant may be prepared by the construction of an expression vector carrying the DNA encoding the variant.
  • the expression vector carrying the inserted DNA fragment encoding the CBH2 variant may be any vector which is capable of replicating autonomously in a given host organism or of integrating into the DNA of the host, typically a plasmid.
  • two types of expression vectors for obtaining expression of genes are contemplated. The first contains DNA sequences in which the promoter, gene-coding region, and terminator sequence all originate from the gene to be expressed.
  • Gene truncation may be obtained where desired by deleting undesired DNA sequences (e.g., coding for unwanted domains) to leave the domain to be expressed under control of its own transcriptional and translational regulatory sequences.
  • a selectable marker may also be contained on the vector allowing the selection for integration into the host of multiple copies of the novel gene sequences.
  • the second type of expression vector is preassembled and contains sequences required for high-level transcription and a selectable marker. It is contemplated that the coding region for a gene or part thereof can be inserted into this general-purpose expression vector such that it is under the transcriptional control of the expression cassettes promoter and terminator sequences.
  • pRAX is such a general-purpose expression vector. Genes or part thereof can be inserted downstream of the strong glaa promoter.
  • pTEX is such a general-purpose expression vector. Genes or part thereof can be inserted downstream of the strong cbh1 promoter.
  • the DNA sequence encoding the CBH2 variant of the present disclosure should be operably linked to transcriptional and translational sequences, i.e., a suitable promoter sequence and signal sequence in reading frame to the structural gene.
  • the promoter may be any DNA sequence that shows transcriptional activity in the host cell and may be derived from genes encoding proteins either homologous or heterologous to the host cell.
  • An optional signal peptide provides for extracellular production of the CBH2 variant.
  • the DNA encoding the signal sequence is preferably that which is naturally associated with the gene to be expressed, however the signal sequence from any suitable source, for example an exo-cellobiohydrolase or endoglucanase from Trichoderma, is contemplated in the present disclosure.
  • the DNA vector or construct described above may be introduced in the host cell in accordance with known techniques such as transformation, transfection, microinjection, microporation, biolistic bombardment and the like.
  • Hyprocrea sp. the permeability of the cell wall to DNA in Hyprocrea sp.
  • Hyprocrea sp. Trichoderma sp.
  • uptake of the desired DNA sequence, gene or gene fragment is at best minimal.
  • the preferred method in the present disclosure to prepare Aspergillus sp. or Hyprocrea sp. (Trichoderma sp.) for transformation involves the preparation of protoplasts from fungal mycelium. See Campbell et al. Improved transformation efficiency of A. niger using homologous niaD gene for nitrate reductase. Curr. Genet. 16:53-56; 1989 .
  • the mycelium can be obtained from germinated vegetative spores.
  • the mycelium is treated with an enzyme that digests the cell wall resulting in protoplasts.
  • the protoplasts are then protected by the presence of an osmotic stabilizer in the suspending medium.
  • These stabilizers include sorbitol, mannitol, potassium chloride, magnesium sulfate and the like. Usually the concentration of these stabilizers varies between 0.8 M and 1.2 M. It is preferable to use about a 1.2 M solution of sorbitol in the suspension medium.
  • Uptake of the DNA into the host strain is dependent upon the calcium ion concentration. Generally between about 10 mM CaCl.sub.2 and 50 mM CaCl.sub.2 is used in an uptake solution. Besides the need for the calcium ion in the uptake solution, other items generally included are a buffering system such as TE buffer (10 Mm Tris, pH 7.4; 1 mM EDTA) or 10 mM MOPS, pH 6.0 buffer (morpholinepropanesulfonic acid) and polyethylene glycol (PEG).
  • TE buffer 10 Mm Tris, pH 7.4; 1 mM EDTA
  • MOPS pH 6.0 buffer (morpholinepropanesulfonic acid)
  • PEG polyethylene glycol
  • the polyethylene glycol acts to fuse the cell membranes thus permitting the contents of the medium to be delivered into the cytoplasm of the host cell, by way of example either Aspergillus sp. or Hyprocrea sp. strain, and the plasmid DNA is transferred to the nucleus. This fusion frequently leaves multiple copies of the plasmid DNA integrated into the host chromosome.
  • a suspension containing the Aspergillus sp. protoplasts or cells that have been subjected to a permeability treatment at a density of 10.sup.5 to 10.sup.6/mL, preferably 2.times.10.sup.5/mL are used in transformation.
  • a suspension containing the Hyprocrea sp. (Trichoderma sp.) protoplasts or cells that have been subjected to a permeability treatment at a density of 10.sup.8 to 10.sup.9/mL, preferably 2.times.10.sup.8/mL are used in transformation.
  • a volume of 100.mu.L of these protoplasts or cells in an appropriate solution (e.g., 1.2 M sorbitol; 50 mM CaCl.sub.2) are mixed with the desired DNA.
  • an appropriate solution e.g., 1.2 M sorbitol; 50 mM CaCl.sub.2
  • PEG poly(ethylene glycol)
  • Additives such as dimethyl sulfoxide, heparin, spermidine, potassium chloride and the like may also be added to the uptake solution and aid in transformation.
  • the mixture is then incubated at approximately 0.degree. C. for a period of between 10 to 30 minutes. Additional PEG is then added to the mixture to further enhance the uptake of the desired gene or DNA sequence.
  • the 25% PEG 4000 is generally added in volumes of 5 to 15 times the volume of the transformation mixture; however, greater and lesser volumes may be suitable.
  • the 25% PEG 4000 is preferably about 10 times the volume of the transformation mixture.
  • the transformation mixture is then incubated either at room temperature or on ice before the addition of a sorbitol and CaCl.sub.2 solution.
  • the protoplast suspension is then further added to molten aliquots of a growth medium. This growth medium permits the growth of transformants only.
  • Any growth medium can be used in the present disclosure that is suitable to grow the desired transformants. However, if Pyr.sup.+ transformants are being selected it is preferable to use a growth medium that contains no uridine. The subsequent colonies are transferred and purified on a growth medium depleted of uridine.
  • stable transformants may be distinguished from unstable transformants by their faster growth rate and, in Trichoderma, for example, the formation of circular colonies with a smooth, rather than ragged outline on solid culture medium lacking uridine. Additionally, in some cases a further test of stability may made by growing the transformants on solid non-selective medium (i.e. containing uridine), harvesting spores from this culture medium and determining the percentage of these spores which will subsequently germinate and grow on selective medium lacking uridine.
  • solid non-selective medium i.e. containing uridine
  • the CBH2 variant(s) are recovered in active form from the host cell after growth in liquid media as a result of the appropriate post translational processing of the CBH2 variant.
  • the present disclosure also contemplates the use of yeast as a host cell for CBH2 production.
  • genes encoding hydrolytic enzymes have been expressed in various strains of the yeast S. cerevisiae. These include sequences encoding for two endoglucanases ( Penttila et al., Yeast vol. 3, pp 175-185, 1987 ), two cellobiohydrolases ( Penttila et al., Gene, 63: 103-112, 1988 ) and one beta-glucosidase from Trichoderma reesei ( Cummings and Fowler, Curr. Genet.
  • the disclosure further provides cells and cell compositions which have been genetically modified to comprise an exogenously provided variant CBH2-encoding nucleic acid sequence.
  • a parental cell or cell line may be genetically modified (i.e., transduced, transformed or transfected) with a cloning vector or an expression vector.
  • the vector may be, for example, in the form of a plasmid, a viral particle, a phage, etc, as further described above.
  • the methods of transformation of the present disclosure may result in the stable integration of all or part of the transformation vector into the genome of the filamentous fungus. However, transformation resulting in the maintenance of a self-replicating extrachromosomal transformation vector is also contemplated.
  • Trichoderma reesei cell lines that express large quantities of the heterologus protein.
  • Some of the published methods for the introduction of DNA constructs into cellulase-producing strains of Trichoderma include Lorito, Hayes, DiPietro and Harman, 1993, Curr. Genet. 24: 349-356 ; Goldman, VanMontagu and Herrera-Estrella, 1990, Curr. Genet. 17:169-174 ; Penttila, Nevalainen, Ratto, Salminen and Knowles, 1987, Gene 6: 155-164 , for Aspergillus Yelton, Hamer and Timberlake, 1984, Proc. Natl. Acad. Sci.
  • a heterologous nucleic acid construct into filamentous fungi (e.g., H. jecorina)
  • filamentous fungi e.g., H. jecorina
  • permeabilization of filamentous fungi cells walls prior to the transformation process e.g., by use of high concentrations of alkali, e.g., 0.05 M to 0.4 M CaCl.sub.2 or lithium acetate
  • protoplast fusion e.g., Agrobacterium mediated transformation.
  • An exemplary method for transformation of filamentous fungi by treatment of protoplasts or spheroplasts with polyethylene glycol and CaCl.sub.2 is described in Campbell, E. I. et al., Curr. Genet. 16:53-56, 1989 and Penttila, M. et al., Gene, 63:11-22, 1988 .
  • Any of the well-known procedures for introducing foreign nucleotide sequences into host cells may be used. These include the use of calcium phosphate transfection, polybrene, protoplast fusion, electroporation, biolistics, liposomes, microinjection, plasma vectors, viral vectors and any of the other well known methods for introducing cloned genomic DNA, cDNA, synthetic DNA or other foreign genetic material into a host cell (see, e.g., Sambrook et al., supra). Also of use is the Agrobacterium-mediated transfection method described in U.S. Pat. No. 6,255,115 . It is only necessary that the particular genetic engineering procedure used be capable of successfully introducing at least one gene into the host cell capable of expressing the heterologous gene.
  • heterologous nucleic acid constructs comprising a variant CBH2-encoding nucleic acid sequence can be transcribed in vitro, and the resulting RNA introduced into the host cell by well-known methods, e.g., by injection.
  • the disclosure further includes novel and useful transformants of filamentous fungi such as H. jecorina and A . niger for use in producing fungal cellulase compositions.
  • the disclosure includes transformants of filamentous fungi especially fungi comprising the variant CBH2 coding sequence, or deletion of the endogenous cbh coding sequence.
  • the genetically modified cells can be cultured in conventional nutrient media modified as appropriate for activating promoters, selecting transformants or amplifying expression of a variant CBH2-encoding nucleic acid sequence.
  • the culture conditions such as temperature, pH and the like, are those previously used for the host cell selected for expression, and will be apparent to those skilled in the art.
  • the progeny of cells into which such heterologous nucleic acid constructs have been introduced are generally considered to comprise the variant CBH2-encoding nucleic acid sequence found in the heterologous nucleic acid construct.
  • the disclosure further includes novel and useful transformants of filamentous fungi such as H. jecorina for use in producing fungal cellulase compositions. Aspergillus niger may also be used in producing the variant CBH2.
  • the disclosure includes transformants of filamentous fungi especially fungi comprising the variant cbh 2 coding sequence, or deletion of the endogenous cbh2 coding sequence.
  • Stable transformants of filamentous fungi can generally be distinguished from unstable transformants by their faster growth rate and, in Trichoderma, for example, the formation of circular colonies with a smooth rather than ragged outline on solid culture medium. Additionally, in some cases, a further test of stability can be made by growing the transformants on solid non-selective medium, harvesting the spores from this culture medium and determining the percentage of these spores which will subsequently germinate and grow on selective medium.
  • a variant CBH2 protein produced in cell culture is secreted into the medium and may be purified or isolated, e.g., by removing unwanted components from the cell culture medium.
  • a variant CBH2 protein may be produced in a cellular form necessitating recovery from a cell lysate.
  • the variant CBH2 protein is purified from the cells in which it was produced using techniques routinely employed by those of skill in the art. Examples include, but are not limited to, affinity chromatography ( Tilbeurgh et al., FEBS Lett. 16:215, 1984 ), ion-exchange chromatographic methods ( Goyal et al., Bioresource Technol.
  • the variant CBH2 protein is fractionated to segregate proteins having selected properties, such as binding affinity to particular binding agents, e.g., antibodies or receptors; or which have a selected molecular weight range, or range of isoelectric points.
  • the CBH2 protein thereby produced is purified from the cells or cell culture.
  • Exemplary procedures suitable for such purification include the following: antibody-affinity column chromatography, ion exchange chromatography; ethanol precipitation; reverse phase HPLC; chromatography on silica or on a cation-exchange resin such as DEAE; chromatofocusing; SDS-PAGE; ammonium sulfate precipitation; and gel filtration using, e.g., Sephadex G-75.
  • Various methods of protein purification may be employed and such methods are known in the art and described e.g. in Deutscher, Methods in Enzymology, vol. 182, no. 57, pp. 779, 1990 ; Scopes, Methods Enzymol. 90: 479-91, 1982 .
  • the purification step(s) selected will depend, e.g., on the nature of the production process used and the particular protein produced.
  • variant cbh nucleic acids find utility in a wide variety applications, some of which are described below.
  • New and improved cellulase compositions that comprise varying amounts BG-type, EG-type and variant CBH-type cellulases find utility in detergent compositions that exhibit enhanced cleaning ability, function as a softening agent and/or improve the feel of cotton fabrics (e.g., "stone washing” or “biopolishing"), in compositions for degrading wood pulp into sugars (e.g., for bio-ethanol production), and/or in feed compositions.
  • the isolation and characterization of cellulase of each type provides the ability to control the aspects of such compositions.
  • the cellulase of the disclosure finds utility in detergent compositions or in the treatment of fabrics to improve the feel and appearance.
  • the rate of hydrolysis of cellulosic products may be increased by using a transformant having at least one additional copy of the cbh gene inserted into the genome, products that contain cellulose or heteroglycans can be degraded at a faster rate and to a greater extent.
  • Products made from cellulose such as paper, cotton, cellulosic diapers and the like can be degraded more efficiently in a landfill.
  • the fermentation product obtainable from the transformants or the transformants alone may be used in compositions to help degrade by liquefaction a variety of cellulose products that add to the overcrowded landfills.
  • Separate saccharification and fermentation is a process whereby cellulose present in biomass, e.g., corn stover, is converted to glucose and subsequently yeast strains convert glucose into ethanol.
  • Simultaneous saccharification and fermentation is a process whereby cellulose present in biomass, e.g., corn stover, is converted to glucose and, at the same time and in the same reactor, yeast strains convert glucose into ethanol.
  • the variant CBH type cellulase of the disclosure finds utility in the degradation of biomass to ethanol. Ethanol production from readily available sources of cellulose provides a stable, renewable fuel source.
  • Cellulose-based feedstocks are comprised of agricultural wastes, grasses and woods and other low-value biomass such as municipal waste (e.g., recycled paper, yard clippings, etc.). Ethanol may be produced from the fermentation of any of these cellulosic feedstocks. However, the cellulose must first be converted to sugars before there can be conversion to ethanol.
  • feedstocks may be used with the inventive variant CBH and the one selected for use may depend on the region where the conversion is being done. For example, in the Midwestern United States agricultural wastes such as wheat straw, corn stover and bagasse may predominate while in California rice straw may predominate. However, it should be understood that any available cellulosic biomass may be used in any region.
  • the methods of the present disclosure can be used in the production of monosaccharides, disaccharides, and polysaccharides as chemical or fermentation feedstocks for microorganism for the production of organic products, chemicals and fuels, plastics, and other products or intermediates.
  • processing residues dried distillers grain, spent grains from brewing, sugarcane bagasse, etc.
  • hemicellulose partial or complete solubilization of cellulose or hemicellulose.
  • some chemicals that can be produced from cellulose and hemicellulose include, acetone, acetate, glycine, lysine, organic acids (e.g., lactic acid), 1,3-propanediol, butanediol, glycerol, ethylene glycol, furfural, polyhydroxyalkanoates, cis, cis-muconic acid, animal feed and xylose.
  • a cellulase composition containing an enhanced amount of cellobiohydrolase finds utility in ethanol production.
  • Ethanol from this process can be further used as an octane enhancer or directly as a fuel in lieu of gasoline which is advantageous because ethanol as a fuel source is more environmentally friendly than petroleum derived products. It is known that the use of ethanol will improve air quality and possibly reduce local ozone levels and smog. Moreover, utilization of ethanol in lieu of gasoline can be of strategic importance in buffering the impact of sudden shifts in non-renewable energy and petrochemical supplies.
  • Ethanol can be produced via saccharification and fermentation processes from cellulosic biomass such as trees, herbaceous plants, municipal solid waste and agricultural and forestry residues.
  • cellulosic biomass such as trees, herbaceous plants, municipal solid waste and agricultural and forestry residues.
  • the ratio of individual cellulase enzymes within a naturally occurring cellulase mixture produced by a microbe may not be the most efficient for rapid conversion of cellulose in biomass to glucose.
  • endoglucanases act to produce new cellulose chain ends which themselves are substrates for the action of cellobiohydrolases and thereby improve the efficiency of hydrolysis of the entire cellulase system. Therefore, the use of increased or optimized cellobiohydrolase activity may greatly enhance the production of ethanol.
  • the inventive cellobiohydrolase finds use in the hydrolysis of cellulose to its sugar components.
  • a variant cellobiohydrolase is added to the biomass prior to the addition of a fermentative organism.
  • a variant cellobiohydrolase is added to the biomass at the same time as a fermentative organism.
  • the cellulosic feedstock may be pretreated.
  • Pretreatment may be by elevated temperature and the addition of either of dilute acid, concentrated acid or dilute alkali solution.
  • the pretreatment solution is added for a time sufficient to at least partially hydrolyze the hemicellulose components and then neutralized.
  • the major product of CBH2 action on cellulose is cellobiose which is available for conversion to glucose by BG activity (for instance in a fungal cellulase product).
  • cellobiose which is available for conversion to glucose by BG activity (for instance in a fungal cellulase product).
  • other sugars in addition to glucose and cellobiose, can be made available from the biomass.
  • the hemi-cellulose content of the biomass can be converted (by hemi-cellulases) to sugars such as xylose, galactose, mannose and arabinose.
  • enzymatic saccharification can produce sugars that are made available for biological or chemical conversions to other intermediates or end-products.
  • the sugars generated from biomass find use in a variety of processes in addition to the generation of ethanol.
  • Examples of such conversions are fermentation of glucose to ethanol (as reviewed by M. E. Himmel et al. pp 2-45, in “Fuels and Chemicals from Biomass", ACS Symposium Series 666, ed B. C. Saha and J. Woodward, 1997 ) and other biological conversions of glucose to 2,5-diketo-D-gluconate ( U.S. Pat. No. 6,599,722 ), lactic acid (R. Datta and S-P. Tsai pp 224-236, ibid), succinate (R. R. Gokarn, M. A. Eiteman and J.
  • Sridhar pp 237-263, ibid) 1,3-propanediol (A-P. Zheng, H. Biebl and W-D. Deckwer pp 264-279, ibid), 2,3-butanediol (C. S. Gong, N. Cao and G. T. Tsao pp 280-293, ibid), and the chemical and biological conversions of xylose to xylitol (B. C. Saha and R. J. Bothast pp 307-319, ibid). See also, for example, WO 98/21339 .
  • the detergent compositions of this disclosure may employ besides the cellulase composition (irrespective of the cellobiohydrolase content, i.e., cellobiohydrolase-free, substantially cellobiohydrolase-free, or cellobiohydrolase enhanced), a surfactant, including anionic, non-ionic and ampholytic surfactants, a hydrolase, building agents, bleaching agents, bluing agents and fluorescent dyes, caking inhibitors, solubilizers, cationic surfactants and the like. All of these components are known in the detergent art.
  • a surfactant including anionic, non-ionic and ampholytic surfactants, a hydrolase, building agents, bleaching agents, bluing agents and fluorescent dyes, caking inhibitors, solubilizers, cationic surfactants and the like. All of these components are known in the detergent art.
  • the cellulase composition as described above can be added to the detergent composition either in a liquid diluent, in granules, in emulsions, in gels, in pastes, and the like. Such forms are well known to the skilled artisan.
  • the cellulase composition is preferably formulated as granules.
  • the granules can be formulated so as to contain a cellulase protecting agent.
  • the cellulase compositions are employed from about 0.00005 weight percent to about 5 weight percent relative to the total detergent composition. More preferably, the cellulase compositions are employed from about 0.0002 weight percent to about 2 weight percent relative to the total detergent composition.
  • variant CBH2 nucleic acid sequence finds utility in the identification and characterization of related nucleic acid sequences.
  • a number of techniques useful for determining (predicting or confirming) the function of related genes or gene products include, but are not limited to, (A) DNA/RNA analysis, such as (1) overexpression, ectopic expression, and expression in other species; (2) gene knock-out (reverse genetics, targeted knock-out, viral induced gene silencing (VIGS, see Baulcombe, 100 Years of Virology, Calisher and Horzinek eds., Springer-Verlag, New York, N.Y.
  • M molar
  • mM millimolar
  • ⁇ M micromolar
  • nM nanomolar
  • mol mole
  • mmol millimoles
  • ⁇ mol micromol
  • nmol nanomoles
  • gm grams
  • mg milligrams
  • ⁇ g micrograms
  • pg picograms
  • L liters
  • ml and mL milliliters
  • ⁇ l and ⁇ L microliters
  • This Example describes the treatment of a commercial Trichoderma sp. cellulase preparation (LAMINEX BG enzyme complex (Genencor Division, Danisco US, Inc.) with succinic anhydride to acetylate the lysine residues. Acetylation of the lysine residues of the LAMINEX BG enzyme complex alters the net charge of the proteins (e.g., increased negative charge).
  • LAMINEX BG enzyme complex Genencor Division, Danisco US, Inc.
  • Lysine residues on a cellulase preparation were modified using succinic anhydride, using a variation of published methods ( Lundblad, Chemical Reagents for Protein Modification, Editor: R. Lundblad, 3rd Edition CRC press, 1984 ).
  • a 236 mg sample of LAMINEX BG enzyme complex was prepared in 1 mL of 500 mM HEPES buffer pH 8.
  • a succinic anhydride (Aldrich) solution was prepared by dissolving the powder in DMSO to a 500mg/mL final concentration before addition of the enzyme complex. An aliquot of succinic anhydride was added such that a ratio of > 1:100 lysine to succinic acid was achieved in the reaction tube.
  • reaction tube was set up with DMSO and enzyme only, using similar volumes, to serve as the unmodified protein control.
  • the tubes were vortexed and left at room temp overnight. The following day, a 1:10 volume of 1M glycine pH 3 was added to each tube to quench the succinic anhydride reaction.
  • This Example describes determining the zeta potential of an enzyme and a substrate.
  • the presence of a charge on the surface of a particle influences the distribution of ions in the surrounding interfacial region.
  • the result is an increased concentration of counter ions of opposite charge to that of the particle near the particle surface.
  • the heterogeneous distribution of ions will eventually become homogeneous.
  • the distance at which a homogenous distribution is obtained is called the Debye length (1/ ⁇ or screening distance, and is dependent upon the ionic strength as shown in the expression below, where ⁇ 0 is the permittivity of free space (8.854 x 10 -12 F m -1 ), ⁇ r is the permittivity of the liquid, k is the Boltzmann constant (1.38 x 10 -23 J K -1 ), T is the temperature in Kelvin, e is the electronic charge (1.6022 x 10 -19 C), I is the molar ionic strength, and NA is Avogadro's constant (6.022 x 10 23 mol -1 ).
  • the liquid layer surrounding the particle exists as two parts; an inner region (Stem layer) where the ions are strongly bound and an outer (diffuse) region where they are less firmly associated.
  • the diffuse layer there is a boundary inside which the ions and particles form a stable entity. When a particle moves, ions within this boundary move with it. Those ions beyond the boundary do not travel with the particle.
  • the electric potential at this boundary also called the surface of hydrodynamic shear, is defined as the zeta potential.
  • the zeta potential is calculated from the measured electrophoretic mobilityu u using the Henry equation shown below, where ⁇ is the dielectric constant, h is the solution viscosity, ⁇ is the inverse Debye length, a is the particle radius, and f ( ka ) is the Henry function.
  • u 2 ⁇ ez 3 ⁇ h ⁇ f ka
  • the units of ⁇ are reciprocal length, with 1/ ⁇ being the "thickness" of the electrical double layer (Debye length).
  • the parameter a refers to the radius of the particle, and therefore, ⁇ a is the ratio of the particle radius to the electrical double layer thickness.
  • Zeta potentials of proteins were measured with the Zetasizer NS (Malvern Instruments, UK) according to the principle outlined above. Zeta potentials of BMI-stained fabrics were measured with the SurPass (Anton-Paar, Austria) using the streaming potential implementation of the above principle.
  • Electrophoretic mobility measured with native gels is usually less than in solution due to retardation caused by the gel matrix. Zeta potentials calculated this way are usually lower compared to solution-based methods. We therefore refer to them as apparent zeta potentials when obtained via the native gel technique.
  • the effective charge in a given formulation is enumerated as its zeta potential.
  • zeta potential as a common charge scale allows comparison of enzyme variants having different folds (e.g., serine proteases, metalloproteases, etc.), as well as interactions with different substrates (e.g., BMI microswatch) under the conditions of interest (e.g., AATCC HDL detergent).
  • zeta potential is preferred for comparing different protein folds, electrophoretic mobilities or measured charges also provide an absolute scale and are adequate for comparisons.
  • BMI performance as a function of enzyme zeta potential is well described by a standard normal distribution, indicated by the solid line, with a mean ⁇ equal to -9.68 mV, standard deviation ⁇ of 11.39 mV and peak value of 0.4056 [A600-background].
  • This distribution is indicated in standard reduced coordinates by the BMI activity divided by the peak value on the right Y-axis as a function of the Z score on the top X-axis.
  • the Z score is defined as usual as (X- ⁇ )/ ⁇ where X in this case is zeta potential. Table 1-1.
  • the normal distribution is unique to each substrate stain under given reaction conditions (pH, conductivity, type of salt, detergent chelators, etc.). Different benefits or favorable outcomes follow a normal distribution with a physical property that holds across enzymes from various folds, as is for instance, the case of expression levels and zeta potentials for ASP and NprE charge ladder variants. In a normal distribution the peak value occurs at the mean. Comparison of enzyme and substrate charges on a common zeta potential scale reveals that optimum BMI performance occurs when the mean enzyme zeta potential in this case -9.68 mV, essentially matches the substrate stain zeta potential, in this case -8.97 mV, measured under the same conditions.
  • Different substrate stains e.g ., grass, body soils, tomato
  • the same substrate stain has different zeta potentials under different formulations (e.g ., North American HDL, European powder dishwashing detergent).
  • the standard deviation of the normal distribution is expected to remain constant.
  • Knowledge of enzyme and substrate zeta potentials in a given detergent formulation allows rapid identification of the expected performance level for that variant, as well as the direction and magnitude of charge change needed in order to achieve optimal performance levels.
  • Measurement of the substrate zeta potential in the desired reaction medium allows optimization of the enzyme reaction on the particulate substrate in that medium. Any enzyme reaction in any medium can be optimized using a similar process.
  • Cellulose conversion was evaluated by techniques known in the art (See, e.g., Baker et al., Appl Biochem Biotechnol, 70-72:395-403, 1998 ).
  • a standard cellulosic conversion assay was used in the experiments. In this assay enzyme and buffered substrate were placed in containers and incubated at a temperature over time. The reaction was quenched with enough 100 mM glycine, pH 11, to bring the pH of the reaction mixture to at least pH 10. Once the reaction was quenched, an aliquot of the reaction mixture was filtered through a 0.2 micron membrane to remove solids. The filtered solution was then assayed for soluble sugars by HPLC according to the methods described in Baker et al., above.
  • Corn stover was pretreated with 2% w/w H 2 SO 4 as described ( Schell et al., J Appl Biochem Biotechnol, 105:69 - 86 [2003 ]) and followed by multiple washes with deionized water to obtain a pH of 4.5. Sodium acetate was added to make a final concentration of 50mM and the solution was titrated to pH 5.0. The cellulose concentration in the reaction mixture was approximately 7%.
  • UK Malvern Instruments
  • Table 1-2 indicates that throughout the course of the saccharification reaction the PCS substrate charge, expressed as zeta potential, nearly became twice as negative. Without being bound by theory, there are many explanations for a net negative charge increase including but not limited to enrichment in lignin, the non-reactive portion of this substrate, as well as nonproductive binding or fouling of whole cellulases and other proteins.
  • There is an optimal enzyme zeta potential for performance e.g., extent of reaction and reaction rate
  • Different biomass pretreatments may dramatically influence initial substrate charge. If the enzyme or the substrate become zeta potential mismatched throughout the course of the reaction, the enzyme-substrate interaction will no longer be optimal. This effect will be dramatic for changes of nearly 10 mV, which are the case for biomass conversion.
  • Residual glucose from H. jecorina culture supernatants expressing CBH2 variants was measured using a hexokinase assay. A volume of 5 ⁇ l of supernatant was added to 195 ⁇ l glucose hexokinase assay (Instrumentation Laboratory, Breda, Netherlands) in a 96-well microtiterplate (Costar Flat Bottom PS). The plates were incubated at room temperature for 15 min. Following incubation, the absorbance was measured at 340 nm OD. Supernatants of cultures expressing residual glucose were excluded from pooling for further studies.
  • the concentration of CBH2 variant proteins from pooled culture supernantants was determined using an Agilent 1100 (Hewlet Packard) HPLC equipped with a Proswift RP 2H column (Dionex). Ten microliters of sample, mixed with 50 ⁇ l of 10% acetonitrile in filtered demineralized water was injected following equilibration of the HPLC column with 10% acetonitrile containing 0.01% trifluoroacetic acid. Compounds were eluted using a gradient of 10% to 30% acetonitrile from 0.3 min to 1 min, followed by a gradient of 30% to 65% from 1 min to 4 mins.
  • Protein concentrations of CBH2 variants were determined from a calibration curve generated using purified wild-type CBH2 (6.25, 12.5, 25, 50 ⁇ g/ml). To calculate performance index (P i or PI), the ratio of the (average) total protein produced by a variant and (average) total protein produced by the wild-type at the same dose were averaged.
  • Phosphoric acid swollen cellulose was prepared from Avicel according to a published method ( Walseth, Tappi 35:228, 1971 ; and Wood, Biochem J, 121:353-362, 1971 ). This material was diluted with buffer and water to achieve a 1% w/v mixture such that the final concentration of sodium acetate was 50mM, pH 5.0.
  • One hundred microliters of a 1% suspension of PASC in 50 mM sodium acetate buffer (pH5.0) was dispensed in a 96-well microtiterplate (Costar Flat Bottom PS).
  • PAHBAH assay Aliquots of 150 ⁇ l of PAHBAH reducing sugar reagent (5% w/v p-hydroxybenzoic acid hydrazide (PAHBAH, Sigma # H9882, dissolved in 0.5 N HCl), ( Lever, Anal Biochem, 47:273-279, 1972 ) were added to all wells of an empty microtiter plate. Ten microliters of the hydrolysis reaction supernatants were added to the PABAH reaction plate. All plates were sealed and incubated at 69°C under continuous shaking of 900 rpm. After one hour the plates were placed on ice for five minutes and centrifuged at 720 x g at room temperature for five minutes.
  • PCS Pretreated Corn Stover
  • PAHBAH assay Aliquots of 150 ⁇ l of PAHBAH reducing sugar reagent (5% w/v p-hydroxybenzoic acid hydrazide (PAHBAH, Sigma # H9882, dissolved in 0.5 N HCl), ( Lever, Anal Biochem, 47:273-279, 1972 ) were added to all wells of an empty microtiter plate. Ten microliters of the hydrolysis reaction supernatants were added to the PABAH reaction plate. All plates were sealed and incubated at 69°C under continuous shaking of 900 rpm. After one hour the plates were placed on ice for five minutes and centrifuged at 720 x g at room temperature for five minutes.
  • thermostability of wild-type CBH2 and CBH2 variants was tested at 53°C.
  • Pooled culture supernatant (80 ⁇ L) of H. jecorina cells expressing CBH2 variants were added to a 96-well plate (Greiner V-bottom PS).
  • the plates were sealed and incubated in a thermostatted incubator at 53°C for 16 hours with shaking at 900 rpm. Following incubation, the plates were placed on ice for 5 minutes. Residual CBH2 activity was determined using the phosphoric acid swollen cellulose (PASC) hydrolysis assay as described above.
  • PASC phosphoric acid swollen cellulose
  • the value of the product formed by the addition of 5, 10, 15 and 20 ⁇ l of heat-treated CBH2 to the residual activity PASC assay was divided by the value of the product formed by the addition of 5, 10, 15 and 20 ⁇ l of unheated CBH2 to the PASC assay. The individual values of these four ratios were then averaged to give the average residual activity.
  • the value of average residual activity for the variants was then divided by the average of the residual activity values of the wild-type CBH2 controls.
  • Lignin a complex biopolymer of phenylpropanoid
  • lignin minimizes the accessibility of cellulose and hemicellulose to cellulose degrading enzymes.
  • lignin is generally associated with reduced digestibility of all plant biomass.
  • the binding of cellulases to lignin reduces the degradation of cellulose by cellulases.
  • Lignin is hydrophobic and apparently negatively charged. Thus the addition of negative charges to cellulases is contemplated to reduce their binding to lignin.
  • a reaction was set up to measure the effect of chemical modification on the ability of a Trichoderma sp. cellulase preparation to bind a component of plant polymers, namely lignin.
  • Lignin was recovered by extensive digestion of acid pretreated sugar cane bagasse by cellulases (100 mg Laminex BG/ g of cellulose) followed by hydrolysis of the cellulases by nonspecific serine protease exactly as described in Berlin et al.(Applied Biochemistry and Biotechnology, 121:163-170, 2005 ), except that sonication, drying, grinding and screening were not done and an acid wash (0.1 N HCl) to remove the protease followed by repeated washes with acetate buffer (50 mM sodium acetate pH 5) to return the sample to a of pH 5 were added to the procedure.
  • acetate buffer 50 mM sodium acetate pH 5
  • Bagasse is the biomass that remains after sugarcane has been crushed to extract its juice.
  • a solution containing 2% cellulose of bagasse (acid treated, 28% solid, 57% glycan) was prepared in 50 mM sodium acetate at pH 5.
  • Samples of unmodified or chemically-modified Trichoderma sp. cellulase preparations were diluted ten fold in the same sodium acetate buffer. Aliquots of the diluted enzymes were mixed with either bagasse solution or buffer alone and incubated for 1hr at room temperature. The supernatant was collected and assayed for activity of a component of cellulase, namely beta-glucosidase.
  • Beta-glucosidase activity was measured using the chloro-nitro-phenyl-beta-D-glucoside (CNPG) assay.
  • the CNPG assay is a kinetic assay in which ⁇ -glucosidase converts CNPG to the colored product 2-chloro-4-nitrophenol (CNP). OD is measured at 405 nm over a period of 10 minutes at 37°C. Rates are obtained as Vmax using the SpectraMax software and then converted to specific activity ( ⁇ M CNP/sec/mg Protein). Briefly, 200 ⁇ l of 50 mM sodium acetate buffer pH 5.0 was added to each well of a 96-well microtiter plate.
  • the plate was covered and placed in an Eppendorf Thermomixer at 37°C for 15 minutes to allow it to equilibrate to temperature.
  • a 10 mM CNPG stock solution was diluted 1:5 using 50 mM sodium acetate buffer, pH5.0, then 20 ⁇ l of the diluted CNPG solution (2 mM) was added to each well containing enzyme samples.
  • the microtiter plate was transferred to a spectrophotometer (SpectraMAX, type 340; Molecular Devices) set at 37°C and OD was read at 405 nm for 0-15 min, reading at ⁇ 9 sec intervals.
  • the amount of beta-glucosidase activity of the cellulase enzyme samples that remained unbound to the bagasse substrate was considerably greater in the case of the chemically-modified Trichoderma sp. cellulase preparation.
  • less than 50% of the unmodified beta-glucosidase remained unbound (e.g., 50% bound) to the bagasse substrate, while nearly 80% of the modified bglu remained unbound (e.g., 20% bound) to the bagasse substrate.
  • the modified cellulase binding data indicate that reducing the positive charges on cellulase leads to reduced binding to a more negatively-charged plant polymer substrate.
  • the plant polymer substrate was lignin remaining in acid treated biomass.
  • Acid treated biomass from corn stover a plant biopolymer of similar chemical composition, was demonstrated to adopt an increasingly more negative charged during the course of saccharification, as determined by measurement of zeta potential (See, Table 1-2).
  • Saccharification of cellulose present in acid-pretreated bagasse (APB) containing varying amounts of additional lignin was evaluated using chemically-modified and unmodified Trichoderma sp. cellulase preparations and assayed by HPLC to monitor release of sugars, DPI to DP7. The results are shown on in FIG. 1 as percent conversion of the polymer substrate.
  • APB acid-pretreated bagasse
  • 200 ⁇ L of APB (3.5% glucan) was prepared in 50 mM sodium acetate buffer at pH 5, and adjusted to varying amounts of lignin. Twenty microliters of cellulase enzyme solution (unmodified or modified LAMINEX BG) was added to the wells.
  • the plates were covered with aluminum plate sealers and placed in incubators at 50°C, with shaking, for 24 hrs or 48 hrs.
  • the reaction was terminated by adding 100 ⁇ l 100 mM glycine pH 10 to each well.
  • the contents of the microtiter plate wells were filtered through a Millipore 96-well filter plate (0.45 ⁇ m, PES).
  • the filtrate was diluted into a plate containing 100 ⁇ l 10 mM Glycine pH 10 and the amount of soluble sugars (DP1 through DP7) produced measured by HPLC.
  • the Agilent 1100 series HPLC was equipped with a de-ashing/guard column (Biorad Catalog No. 125-0118) and an Aminex lead based carbohydrate column (Aminex Catalog No.
  • HPX-87P The mobile phase used was water with a 0.6 ml/min flow rate.
  • Soluble sugar standards (DP1-DP7) obtained from Sigma were all diluted in Milli-Q water to 100 mg/mL and used for converting peak area for the individual sugars to actual sugar concentrations. The percent of conversion was calculated by dividing the sugars measured from HPLC by 100% conversion of cellulose to glucose.
  • Cellulase binding to lignin will decrease its efficiency of degrading cellulose. This is demonstrated as a reduction in cellulose conversion in the presence of increasing amounts of lignin present in the saccharification reactions. This trend persists in the modified cellulase preparations. However, there is a 10% increase in cellulose conversion in the modified cellulase samples as compared to unmodified cellulase samples. This result indicates that increasing negative charge of the cellulase reduces the nonproductive binding of cellulase to lignin.
  • CBH2 variant used in this experiment has multiple substitutions (P98L/M134V/T154A/I2112V/S316P/S413Y with numbers corresponding to the wild type mature CBH2 cellulase) as described in US Pub. No. 2006/0205042 .
  • the amino acid sequence of the mature CBH2 variant is as follows:
  • CBH1, CBH2 variant, EG1, EG2 and beta-glucosidase were verified by their shifted mobility on the native gel compared to the unmodified proteins. Modified CBH1, CBH2 variant, EG1, EG2 and beta-glucosidase have more negative charges. All the protein concentrations were measured using a NanoDropTM spectrophotometer (Thermo).
  • a saccharification reaction was set up in microtiter plate, in each well of a microtiter plate, 150 uL of APB (7% glucan prepared as described above for PCS) was prepared in 50 mM sodium acetate buffer at pH 5, 20 ⁇ l of enzyme mix of 21 ⁇ g total protein was added so that the final protein to cellulose ratio in each well is 20mg/g.
  • Six enzyme mixes were made by adding purified modified or unmodified Bglu, CBH2 variant, EG1, or EG2 to a T .
  • the reaction was terminated by adding 100 ⁇ l 100 mM glycine pH 10 to each well. Following thorough mixing, the contents of the microtiter plate wells were filtered through a Millipore 96-well filter plate (0.45 ⁇ m, PES). The filtrate was diluted into a plate containing 100 ⁇ l 10 mM Glycine pH 10 and the amount of soluble sugars (DP1 through DP7) produced measured by HPLC.
  • the Agilent 1100 series HPLC was equipped with a de-ashing/guard column (Biorad Catalog No. 125-0118) and an Aminex lead based carbohydrate column (Aminex Catalog No. HPX-87P). The mobile phase used was water with a 0.6 ml/min flow rate.
  • Soluble sugar standards obtained from Sigma were all diluted in Milli-Q water to 100 mg/mL and used for converting peak area for the individual sugars to actual sugar concentrations. The percent of conversion was calculated by dividing the sugars measured from HPLC by 100% conversion of cellulose to glucose.
  • FIG. 2 A shows that for the sixth enzyme mix (modified EG2, EG1, CBH2 variant and beta-glucosidase) with all protein modified has the highest cellulose conversion, and fifth enzyme mix with all protein unmodified has the lowest conversion. Comparing the first four enzyme mixes, the second enzyme mix with the unmodified CBH2 gave next lowest conversion.
  • FIG. 2B shows the advantages of modified proteins over unmodified proteins in cellulose conversion.
  • SEQ ID NO:1 sets forth the reference Hypocrea jecorina CBH2 coding DNA sequence:
  • SEQ ID NO:2 sets forth the Hypocrea jecorina CBH2 full length protein sequence:
  • SEQ ID NO:3 sets forth the Hypocrea jecorina CBH2 mature protein sequence:
  • Residues selected to be mutagenized included non-conserved, exposed lysine, arginine, asparigine, and glutamine residues, which were selected for substitution to introduce negative charges.
  • Succinylated lysines in modified CBH2 were identified by mass spectrometry and selected for mutagenesis to glutamate, resulting in a -2 charge difference per substitution.
  • Other residues were selected for substitution by analysis of CBH2 three-dimensional structure combined with amino acids alignment of homologous CBH2 sequences (See, e.g., Figure 3 of US Pub. No. US 2006/0205042 , herein incorporated by reference). Surface residues that were highly variable in the CBH2 amino acid sequence alignment were candidates for mutagenesis.
  • CRH2 Substitutions Introduction of negative charge and removal of Removal of positive charge Introduction of negative charge Introduction of negative charge Removal of negative charge Removal of negative charge Removal of negative charge Table 6-1.
  • CBH2 Substitutions positive charge Lysine Arginine Asparagine Glutamine Aspartate Glutamate K157E R153Q N382D Q204E D189N E208Q K129E R294Q N344D Q147E D211N E244Q K288E R203Q N237D Q239E D405N E146Q K194E R378Q N339D Q281E D277N K356E R63Q N289D D151N K327E R77Q N161D N285D N197D N254D N247D
  • CBH2 charge variants (C-1 to C-10) were designed spanning a charge range of +8 to -32, compared to the wild-type CBH2 in steps of 4 as shown in Table 6-2. Table 6-2.
  • the amino acid sequences of the variants were back translated to DNA and codon optimized for expression in Trichoderma reesei using GeneDesigner software (DNA2.0).
  • the codon-optimized cbh2 variant genes were synthesized and the DNA of the CBH2 surface charge variants (SCVs) was amplified from the DNA2.0 constructs by PCR with using primers: GGHTK22 forward 5'-CACCATGATCGTGGGAATTCTTACTACTC-3' (SEQ ID NO:15); and GGTHK23 reverse 5'-CTACAAAAACGAAGGGTTCGCATT-3' (SEQ ID NO:16).
  • site directed mutagenesis was used to introduce K129E and K157E mutations (cbh2 charge variant C-3) in the genomic DNA of wild type CBH2.
  • CBH2 charge variant C-3 was cloned into pTrex3GM and expressed as described below.
  • PCR products were purified and cloned into pENTR/TOPO for transformation of E. coli TOP10 cells. Plasmid DNA was isolated from single colonies and the correct sequence was verified. CBH2 SCVs were cloned into pTrex3GM, pTTTpyr(pcbh1), and pTTTpyr(pstp1) as shown in Table 6-3. Table 6-3.
  • CBH2 surface charge variants (SCV) in T. reesei Biolistic transformation of T. reesei with the pTrex3gM expression vector containing the cbh2 charge variant C3 (with K129E and K157E mutations) open reading frame was performed using the following protocol. T. reesei in which the genes encoding cellobiohydrolase I (CBHI, Ce17a), cellobiohydrolase II (CBHII, Ce16a), endoglucanase I (EGI, Ce17b), and endoglucanase II (EGII, Ce15a) have been inactivated was used.).
  • Transformation of the Trichoderma reesei strain by the biolistic transformation method was accomplished using a Biolistic® PDS-1000/he Particle Delivery System from Bio-Rad (Hercules, CA) following the manufacturer's instructions (See WO 05/001036 and US 2006/0003408 ). Transformants were transferred to new acetamide selection plates.
  • Stable transformants were inoculated into filter microtiter plates (Millipore), containing 200ul/well of glycine minimal media (6.0 g/L glycine; 4.7 g/L (NH 4 ) 2 SO 4 ; 5.0 g/L KH 2 PO 4 ; 1.0 g/L MgSO 4 ⁇ 7H 2 O; 33.0 g/L PIPPS; p.H. 5.5) with post sterile addition of ⁇ 2% glucose/sophorose mixture as the carbon source, 10 ml/L of 100g/L of CaCl 2 , 2.5 ml/L of T.
  • glycine minimal media 6.0 g/L glycine; 4.7 g/L (NH 4 ) 2 SO 4 ; 5.0 g/L KH 2 PO 4 ; 1.0 g/L MgSO 4 ⁇ 7H 2 O; 33.0 g/L PIPPS; p.H. 5.5
  • glycine minimal media 6.0
  • reesei trace elements 400X: 175g/L Citric acid anhydrous; 200g/L FeSO 4 ⁇ 7H 2 O; 16g/L ZnSO 4 ⁇ 7H 2 O; 3.2 g/L CuSO 4 ⁇ 5H 2 O; 1.4 g/L MnSO 4 ⁇ H 2 O; 0.8 g/L H 3 BO 3 .
  • Transformants were grown in liquid culture for 5 days in O 2 rich chamber housed in a 28° C incubator. The supernatant samples from the filter microtiter plate were obtained by using a vacuum manifold. Samples were run on 4-12% NuPAGE gels (Invitrogcn) according to the manufactures instructions. The gel was stained with Simply Blue stain (Invitrogen). Expression of additional CHB2 surface charge variants may be accomplished using this method.
  • the pTTTpyr-cbh2 plasmid containing the Hypocrea jecorina CBH2 protein encoding sequence (SEQ ID NO:1) was sent to BASEClear (Leiden, The Netherlands), GeneArt AG (Regensburg, Germany), and Sloning BioTechnology GmbH (Puchheim, Germany) for the generation of Site Evaluation Libraries (SELs).
  • the plasmid map of pTTTpyr-cbh2 is shown in Figure 5 .
  • a request was made to the vendors for the generation of positional libraries at each of the sites in Hypocrea jecorina CBH2 mature protein (SEQ ID NO:3).
  • the amino acid sequence of CBH2 full length protein is shown in SEQ ID NO:2.
  • SEQ ID NO:1 sets forth the reference Hypocrea jecorina CBH2 coding DNA sequence:
  • SEQ ID NO:2 sets forth the Hypocrea jecorina CBH2 full length protein sequence:
  • SEQ ID NO:3 sets forth the Hypocrea jecorina CBH2 mature protein sequence:
  • pTTTpyr-cbh2 plasmids (p cbh1 , Amp R , Acetamide R ) containing open reading frames encoding CBH2 variant sequences were obtained from the vendors specified above.
  • Protoplasts of H. jecorina strain ( ⁇ eg1, ⁇ eg2, ⁇ cbh1 ⁇ cbh2) were transformed with the pTTTpyr constructs and grown on selective agar containing acetamide at 28°C for 7 days. Briefly, biolistic transformation of H.
  • jecorina was performed using the following protocol and a strain in which the genes encoding cellobiohydrolase I (CBHI, Ce17a), cellobiohydrolase II (CBHII, Ce16a), endoglucanase I (EGI, Ce17b), and endoglucanase II (EGII, Ce15a) have been inactivated. Transformation of the H. jecorina by the biolistic transformation method was accomplished using a Biolistic® PDS-1000/he Particle Delivery System from Bio-Rad (Hercules, CA) following the manufacturer's instructions (See WO 05/001036 and US 2006/0003408 ).
  • reesei trace elements 400X: 175g/L Citric acid anhydrous; 200g/L FeSO 4 ⁇ 7H 2 O; 16g/L ZnSO 4 ⁇ 7H 2 O; 3.2 g/L CuSO 4 ⁇ 5H 2 O; 1.4 g/L MnSO 4 ⁇ H 2 O; 0.8 g/L H 3 BO 3 .
  • Each CBH2 variant was grown in quadruplicate. After sealing the plate with an oxygen permeable membrane, the plates were incubated at 28°C for 6 days, while shaking at 220 rpm. Supernatant was harvested by transferring the culture medium to a microtiter plate under low pressure and tested for residual glucose using the hexokinase assay as described in Example 1.
  • H. jecorina CBH2 charge variants were tested for various properties of interest.
  • the cellulase variants were tested for protein expression using the HPLC assay (HPLC), specific activity using the PASC hydrolysis assay (Act. PASC) and the PCS hydrolysis assay (Act. PCS), stability in the presence of ethanol (EtOH ratio) and thermostability (heat ratio) as described in Example 1.
  • Performance data for CBH2 charge variants are shown in Table 8-1.
  • Performance index (PI) is the ratio of performance of the variant cellulase to the parent or reference cellulase.
  • Table 8-11 shows performance index values (Pi or PI) for variants of Hypocrea jecorina CBH2. Performance indices less than or equal to 0.05 were fixed to 0.05 and indicated in bold italics in the table.
  • Table 8-1 Performance Indexes of CBH2 Charge Variants Variant HPLC PASC sp.ac. PCS sp.ac.
  • Table 9-1 Charge Effect on Activity of CBH2 Variants in a PCS Assay PCS o/e 1 sd o/e 2 sd o/e 3 sd Results Charge change -2.00 1.20 1.20 1.20 >90% confident more than expected -1.00 1.40 1.40 1.40 >99% confident more than expected 0.00 1.03 1.03 as expected 1.00 0.46 0.46 0.46 >95% confident less than expected 2.00 0.00 0.00 0.00 as expected

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Processing Of Solid Wastes (AREA)
  • Detergent Compositions (AREA)
EP13167128.1A 2008-06-06 2009-06-03 Zusammensetzungen und Verfahren mit Cellulasevarianten mit verminderter Affinität gegenüber cellulosefreien Materialien Withdrawn EP2626422A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5950608P 2008-06-06 2008-06-06
EP09759361.0A EP2288698B1 (de) 2008-06-06 2009-06-03 Zusammensetzungen und verfahren mit cellulasevarianten mit verminderter affinität gegenüber cellulosefreien materialien

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
EP09759361.0 Division 2009-06-03
EP09759361.0A Division-Into EP2288698B1 (de) 2008-06-06 2009-06-03 Zusammensetzungen und verfahren mit cellulasevarianten mit verminderter affinität gegenüber cellulosefreien materialien

Publications (1)

Publication Number Publication Date
EP2626422A1 true EP2626422A1 (de) 2013-08-14

Family

ID=41061038

Family Applications (5)

Application Number Title Priority Date Filing Date
EP13167126.5A Withdrawn EP2636734A3 (de) 2008-06-06 2009-06-03 Zusammensetzungen und Verfahren mit Cellulasevarianten mit verminderter Affinität gegenüber cellulosefreien Materialien
EP09759361.0A Not-in-force EP2288698B1 (de) 2008-06-06 2009-06-03 Zusammensetzungen und verfahren mit cellulasevarianten mit verminderter affinität gegenüber cellulosefreien materialien
EP13167128.1A Withdrawn EP2626422A1 (de) 2008-06-06 2009-06-03 Zusammensetzungen und Verfahren mit Cellulasevarianten mit verminderter Affinität gegenüber cellulosefreien Materialien
EP13167130.7A Withdrawn EP2628796A1 (de) 2008-06-06 2009-06-03 Zusammensetzungen und Verfahren mit Cellulasevarianten mit verminderter Affinität gegenüber cellulosefreien Materialien
EP13167127.3A Withdrawn EP2628795A1 (de) 2008-06-06 2009-06-03 Zusammensetzungen und Verfahren mit Cellulasevarianten mit verminderter Affinität gegenüber cellulosefreien Materialien

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP13167126.5A Withdrawn EP2636734A3 (de) 2008-06-06 2009-06-03 Zusammensetzungen und Verfahren mit Cellulasevarianten mit verminderter Affinität gegenüber cellulosefreien Materialien
EP09759361.0A Not-in-force EP2288698B1 (de) 2008-06-06 2009-06-03 Zusammensetzungen und verfahren mit cellulasevarianten mit verminderter affinität gegenüber cellulosefreien materialien

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP13167130.7A Withdrawn EP2628796A1 (de) 2008-06-06 2009-06-03 Zusammensetzungen und Verfahren mit Cellulasevarianten mit verminderter Affinität gegenüber cellulosefreien Materialien
EP13167127.3A Withdrawn EP2628795A1 (de) 2008-06-06 2009-06-03 Zusammensetzungen und Verfahren mit Cellulasevarianten mit verminderter Affinität gegenüber cellulosefreien Materialien

Country Status (16)

Country Link
US (3) US8236542B2 (de)
EP (5) EP2636734A3 (de)
JP (1) JP5690721B2 (de)
KR (1) KR20110020243A (de)
CN (2) CN102057041B (de)
AU (1) AU2009256171B2 (de)
BR (1) BRPI0913624A2 (de)
CA (1) CA2726357A1 (de)
CO (1) CO6331367A2 (de)
DK (1) DK2288698T3 (de)
ES (1) ES2619902T3 (de)
HK (1) HK1156972A1 (de)
MX (2) MX2010013099A (de)
PH (1) PH12013501799A1 (de)
RU (1) RU2486242C2 (de)
WO (1) WO2009149202A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011001006A (es) * 2008-08-01 2011-04-21 Iogen Energy Corp Celulasa de la familia 6 con inactivacion disminuida mediante lignina.
EP2401370A4 (de) 2009-02-27 2013-08-14 Iogen Energy Corp Neuartige lignin-resistente cellulasen
RU2011154243A (ru) 2009-06-03 2013-07-20 ДАНИСКО ЮЭс ИНК. Целлюлазные варианты с улучшенной экспрессией, активностью и/или стабильностью и их применение
MX353237B (es) 2009-09-23 2018-01-08 Danisco Us Inc Enzimas de glicosil hidrolasa novedosas y usos de las mismas.
CN102686736B (zh) 2009-12-23 2017-05-31 丹尼斯科美国公司 提高同步糖化发酵反应效率的方法
EP2534246A4 (de) * 2010-02-11 2013-07-10 Iogen Energy Corp Kohlenhydratbindende module mit reduzierter bindung an lignin
AU2011214327B2 (en) 2010-02-11 2014-09-18 Dsm Ip Assets B.V. Polypeptide having cellobiohydrolase activity and uses thereof
JP2011234683A (ja) * 2010-05-12 2011-11-24 Ｂｉｏ−ｅｎｅｒｇｙ株式会社 セルロースの糖化力が増強された酵母
CN103842515A (zh) 2011-03-17 2014-06-04 丹尼斯科美国公司 降低糖化过程的粘度的方法
AU2013266516A1 (en) 2012-05-21 2014-10-09 Danisco Us Inc. Trichoderma hydrophobin production
CN104870643A (zh) * 2012-12-12 2015-08-26 丹尼斯科美国公司 纤维二糖水解酶的变体
US8778640B1 (en) * 2013-02-12 2014-07-15 Novozymes Inc. Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
US8778641B1 (en) * 2013-02-12 2014-07-15 Novozymes Inc. Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
US9850512B2 (en) 2013-03-15 2017-12-26 The Research Foundation For The State University Of New York Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield
US9951363B2 (en) 2014-03-14 2018-04-24 The Research Foundation for the State University of New York College of Environmental Science and Forestry Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects
JP6470967B2 (ja) * 2014-12-25 2019-02-13 花王株式会社 変異キシラナーゼ
WO2017007907A1 (en) 2015-07-07 2017-01-12 Danisco Us Inc. Induction of gene expression using a high concentration sugar mixture
CN108883400B (zh) 2016-02-19 2021-09-17 洲际大品牌有限责任公司 由生物质源形成多值料流的方法
FI3419991T3 (fi) 2016-03-04 2023-01-31 Modifioidut ribosomaaliset promoottorit proteiinien tuottamiseksi mikro-organismeissa
WO2018053058A1 (en) 2016-09-14 2018-03-22 Danisco Us Inc. Lignocellulosic biomass fermentation-based processes
KR102593668B1 (ko) 2016-10-04 2023-10-24 다니스코 유에스 인크. 유도 기질 부재 하의 사상 진균 세포에서의 단백질 생산
WO2018118815A1 (en) 2016-12-21 2018-06-28 Dupont Nutrition Biosciences Aps Methods of using thermostable serine proteases
WO2018124264A1 (ja) 2016-12-28 2018-07-05 富士フイルム株式会社 窒素原子含有ポリマー又はその塩の乳化液、その製造方法、及び粒子の製造方法
WO2019074828A1 (en) 2017-10-09 2019-04-18 Danisco Us Inc CELLOBIOSE DEHYDROGENASE VARIANTS AND METHODS OF USE
TW201922267A (zh) 2017-10-16 2019-06-16 日商富士軟片股份有限公司 高磷血症治療劑
WO2019089898A1 (en) 2017-11-02 2019-05-09 Danisco Us Inc Freezing point depressed solid matrix compositions for melt granulation of enzymes
JP7051491B2 (ja) * 2018-02-26 2022-04-11 花王株式会社 変異β－グルコシダーゼ
DE102019134499A1 (de) * 2019-12-16 2021-06-17 Knorr-Bremse Systeme für Nutzfahrzeuge GmbH Verfahren und Einrichtung zur Bestimmung eines Fahrverhaltens eines Fahrzeugs innerhalb eines Platoons, sowie Fahrzeug mit einer solchen Einrichtung
CN113147764B (zh) * 2021-06-01 2022-08-16 吉林大学 基于协同式自适应巡航系统混合势函数的车辆控制方法
CN116334111B (zh) * 2023-03-03 2024-02-09 上海市农业科学院 一种草菇纤维二糖水解酶及其用途

Citations (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1358599A (en) 1970-12-22 1974-07-03 Monacelli Umberto Gun for firing tacks
GB2094826A (en) 1981-03-05 1982-09-22 Kao Corp Cellulase enzyme detergent composition
GB2095275A (en) 1981-03-05 1982-09-29 Kao Corp Enzyme detergent composition
US4435307A (en) 1980-04-30 1984-03-06 Novo Industri A/S Detergent cellulase
US4822516A (en) 1986-12-08 1989-04-18 Kao Corporation Detergent composition for clothing incorporating a cellulase
WO1991004673A1 (en) 1989-10-06 1991-04-18 Novo Nordisk A/S Feed additive for poultry, poultry feed and method of poultry feeding
WO1992006209A1 (en) 1990-10-05 1992-04-16 Genencor International Inc. Trichoderma reesei containing deleted and/or enriched cellulase and other enzyme genes and cellulase compositions derived therefrom
US5246853A (en) 1990-10-05 1993-09-21 Genencor International, Inc. Method for treating cotton-containing fabric with a cellulase composition containing endoglucanase components and which composition is free of exo-cellobiohydrolase I
WO1994028117A1 (en) 1993-06-02 1994-12-08 Oy Alko Ab Novel endoglucanase enzyme
US5475101A (en) 1990-10-05 1995-12-12 Genencor International, Inc. DNA sequence encoding endoglucanase III cellulase
US5648263A (en) 1988-03-24 1997-07-15 Novo Nordisk A/S Methods for reducing the harshness of a cotton-containing fabric
US5650322A (en) 1990-10-05 1997-07-22 Genencor International, Inc. Methods for stonewashing fabrics using endoglucanases
US5691178A (en) 1988-03-22 1997-11-25 Novo Nordisk A/S Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase
WO1998021339A1 (en) 1996-11-13 1998-05-22 E.I. Du Pont De Nemours And Company Method for the production of 1,3-propanediol by recombinant organisms
WO1998031821A2 (en) 1997-01-17 1998-07-23 Genencor International, Inc. Dna sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi
US5861271A (en) 1993-12-17 1999-01-19 Fowler; Timothy Cellulase enzymes and systems for their expressions
US6162782A (en) 1990-10-05 2000-12-19 Genencor International, Inc. Detergent compositions containing cellulase compositions deficient in CBH I type components
US6255115B1 (en) 1997-04-07 2001-07-03 Unilever Patent Holdings Bv Agrobacterium mediated transformation of moulds, in particular those belonging to the genus Aspergillus
US6599722B2 (en) 1998-12-22 2003-07-29 Genencor International, Inc. Method for producing ascorbic acid intermediates
WO2004056981A2 (en) * 2002-12-20 2004-07-08 Novozymes A/S Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same
WO2005001036A2 (en) 2003-05-29 2005-01-06 Genencor International, Inc. Novel trichoderma genes
US20060003408A1 (en) 2004-05-27 2006-01-05 Nigel Dunn-Coleman Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions
WO2006074005A2 (en) * 2004-12-30 2006-07-13 Genencor International, Inc. Variant hypocrea jecorina cbh2 cellulases
EP1726644A1 (de) * 1996-09-17 2006-11-29 Novozymes A/S Zellulase Varianten
WO2008025164A1 (en) * 2006-08-31 2008-03-06 Iogen Energy Corporation Family 6 cellulases with increased thermostability, thermophilicity, and alkalophilicity
WO2008153925A2 (en) * 2007-06-06 2008-12-18 Danisco Us, Inc., Genencor Division Methods for improving multiple protein properties

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6439600B1 (en) * 2000-03-13 2002-08-27 Am-Safe, Inc. Self-centering airbag and method for manufacturing and tuning the same
JP4897186B2 (ja) 2002-03-27 2012-03-14 花王株式会社 変異アルカリセルラーゼ
DK2295559T3 (en) * 2002-08-16 2015-12-14 Danisco Us Inc Hitherto UNKNOWN HYPROCREA JECORINA CBH1 CELLULASE VARIETY WITH INCREASED THERMAL STABILITY COMPREHENSIVE SUBSTITUTION OR DELETION AT POSITION T255
BRPI0916767A2 (pt) 2008-07-16 2018-10-16 Iogen Energy Corp glicosidades bda família 6 modificadas com especificidade de substrato alterada
MX2011001006A (es) * 2008-08-01 2011-04-21 Iogen Energy Corp Celulasa de la familia 6 con inactivacion disminuida mediante lignina.
MX2011010494A (es) 2009-04-06 2011-12-08 California Inst Of Techn Polipeptidos que tienen actividad de celulasa.
RU2011154243A (ru) 2009-06-03 2013-07-20 ДАНИСКО ЮЭс ИНК. Целлюлазные варианты с улучшенной экспрессией, активностью и/или стабильностью и их применение

Patent Citations (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1358599A (en) 1970-12-22 1974-07-03 Monacelli Umberto Gun for firing tacks
US4435307A (en) 1980-04-30 1984-03-06 Novo Industri A/S Detergent cellulase
GB2094826A (en) 1981-03-05 1982-09-22 Kao Corp Cellulase enzyme detergent composition
GB2095275A (en) 1981-03-05 1982-09-29 Kao Corp Enzyme detergent composition
US4822516A (en) 1986-12-08 1989-04-18 Kao Corporation Detergent composition for clothing incorporating a cellulase
US5691178A (en) 1988-03-22 1997-11-25 Novo Nordisk A/S Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase
US5648263A (en) 1988-03-24 1997-07-15 Novo Nordisk A/S Methods for reducing the harshness of a cotton-containing fabric
US5776757A (en) 1988-03-24 1998-07-07 Novo Nordisk A/S Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase and method of making thereof
WO1991004673A1 (en) 1989-10-06 1991-04-18 Novo Nordisk A/S Feed additive for poultry, poultry feed and method of poultry feeding
US5246853A (en) 1990-10-05 1993-09-21 Genencor International, Inc. Method for treating cotton-containing fabric with a cellulase composition containing endoglucanase components and which composition is free of exo-cellobiohydrolase I
US5650322A (en) 1990-10-05 1997-07-22 Genencor International, Inc. Methods for stonewashing fabrics using endoglucanases
WO1992006209A1 (en) 1990-10-05 1992-04-16 Genencor International Inc. Trichoderma reesei containing deleted and/or enriched cellulase and other enzyme genes and cellulase compositions derived therefrom
US6162782A (en) 1990-10-05 2000-12-19 Genencor International, Inc. Detergent compositions containing cellulase compositions deficient in CBH I type components
US5475101A (en) 1990-10-05 1995-12-12 Genencor International, Inc. DNA sequence encoding endoglucanase III cellulase
WO1994028117A1 (en) 1993-06-02 1994-12-08 Oy Alko Ab Novel endoglucanase enzyme
US5861271A (en) 1993-12-17 1999-01-19 Fowler; Timothy Cellulase enzymes and systems for their expressions
EP1726644A1 (de) * 1996-09-17 2006-11-29 Novozymes A/S Zellulase Varianten
WO1998021339A1 (en) 1996-11-13 1998-05-22 E.I. Du Pont De Nemours And Company Method for the production of 1,3-propanediol by recombinant organisms
WO1998031821A2 (en) 1997-01-17 1998-07-23 Genencor International, Inc. Dna sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi
US6255115B1 (en) 1997-04-07 2001-07-03 Unilever Patent Holdings Bv Agrobacterium mediated transformation of moulds, in particular those belonging to the genus Aspergillus
US6599722B2 (en) 1998-12-22 2003-07-29 Genencor International, Inc. Method for producing ascorbic acid intermediates
WO2004056981A2 (en) * 2002-12-20 2004-07-08 Novozymes A/S Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same
WO2005001036A2 (en) 2003-05-29 2005-01-06 Genencor International, Inc. Novel trichoderma genes
US20070128690A1 (en) 2003-05-29 2007-06-07 Pamela Foreman Novel trichoderma genes
US20060003408A1 (en) 2004-05-27 2006-01-05 Nigel Dunn-Coleman Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions
WO2006074005A2 (en) * 2004-12-30 2006-07-13 Genencor International, Inc. Variant hypocrea jecorina cbh2 cellulases
US20060205042A1 (en) 2004-12-30 2006-09-14 Wolfgang Aehle Novel variant hypocrea jecorina CBH2 cellulases
WO2008025164A1 (en) * 2006-08-31 2008-03-06 Iogen Energy Corporation Family 6 cellulases with increased thermostability, thermophilicity, and alkalophilicity
WO2008153925A2 (en) * 2007-06-06 2008-12-18 Danisco Us, Inc., Genencor Division Methods for improving multiple protein properties

Non-Patent Citations (106)

* Cited by examiner, † Cited by third party
Title
"Program Manual for the Wisconsin Package, Version 8", August 1994, GENETICS COMPUTER GROUP
ABRAMOWITZ; STEGUN: "Handbook of Mathematical Functions with Formulas, Graphs, and Mathematical Tables, 9th Ed.,", 1964, DOVER
ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410
ANALYTICAL BIOCHEMISTRY, vol. 47, 1972, pages 273
APPL. MICROBIOL. BIOTECHNOL., vol. 20, 1984, pages 46 - 53
ARO ET AL., J BIOL CHEM, vol. 276, 2001, pages 24309 - 24314
AUSUBEL ET AL.,: "CURRENT PROTOCOLS IN MOLECULAR BIOLOGY", 1994, GREENE PUBLISHING AND WILEY-INTERSCIENCE
AUSUBEL FM ET AL.: "Current Protocols in Molecular Biology", 1993, JOHN WILEY & SONS
BAJAR; PODILA; KOLATTUKUDY, PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 8202 - 8212
BAKER ET AL., APPL BIOCHEM BIOTECHNOL, vol. 70-72, 1998, pages 395 - 403
BAULCOMBE: "100 Years of Virology", vol. 15, 1999, SPRINGER-VERLAG, pages: 189 - 201
BERGES; BARREAU, CURR. GENET., vol. 19, 1991, pages 359 - 365
BERLIN ET AL., APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 121, 2005, pages 163 - 170
BHIKHABHAI ET AL., J. APPL. BIOCHEM., vol. 6, 1984, pages 336 - 345
BLAKENEY, A. B.; MUTTON, L. L., JOURNAL OF SCIENCE OF FOOD AND AGRICULTURE, vol. 31, 1980, pages 889
BRUMBAUER ET AL., BIOSEPARATION, vol. 7, 1999, pages 287 - 295
CADWELL ET AL., PCR METHODS AND APPLICATIONS, vol. 2, 1992, pages 28 - 33
CAMPBELL ET AL.: "Improved transformation efficiency of A. niger using homologous niaD gene for nitrate reductase", CURR. GENET., vol. 16, 1989, pages 53 - 56
CAMPBELL, E. I ET AL., CURR. GENET., vol. 16, 1989, pages 53 - 56
CARTER ET AL., NUCLEIC ACIDS RES., vol. 13, 1985, pages 4431 - 4443
COLIGAN ET AL., CURRENT PROTOCOLS IN IMMUNOLOGY, 1991
CUMMINGS; FOWLER, CURR. GENET., vol. 29, 1996, pages 227 - 233
DEROSSI; BERTARINI; RICCARDI; MATTEUZZI, FEMS MICROBIOL. LETT., vol. 55, 1990, pages 135 - 138
DEUTSCHER, METHODS IN ENZYMOLOGY, vol. 182, no. 57, 1990, pages 779
ELLOUZ ET AL., J. CHROMATOGRAPHY, vol. 396, 1987, pages 307 - 317
FILHO ET AL., CAN J MICROBIOL, vol. 42, 1996, pages 1 - 5
FLIESS ET AL., EUR. J. APPL. MICROBIOL. BIOTECHNOL., vol. 17, 1983, pages 314 - 318
FREER, J BIOL CHEM, vol. 268, 1993, pages 9337 - 9342
FRESHNEY, ANIMAL CELL CULTURE, 1987
GABORIAUD ET AL., FEBS LETTERS, vol. 224, 1987, pages 149 - 155
GOEDEGEHUUR ET AL., CURR. GENET, vol. 41, 2002, pages 89 - 98
GOLDMAN; VANMONTAGU; HERRERA-ESTRELLA, CURR. GENET., vol. 17, 1990, pages 169 - 174
GOYAL ET AL., BIORESOURCE TECHNOL., vol. 36, 1991, pages 37 - 50
HALE; MARHAM: "THE HARPER COLLINS DICTIONARY OF BIOLOGY", HARPER PERENNIAL
HALLDORSDOTTIR S ET AL., APPL MICROBIOL BIOTECHNOL., vol. 49, no. 3, 1998, pages 277 - 84
HEMMPEL, ITB DYEING/PRINTING/FINISHING, vol. 3, 1991, pages 5 - 14
HENIKOFF; HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1989, pages 10915
HENRY, R. J., JOURNAL OF THE INSTITUTE OF BREWING, vol. 90, 1984, pages 37
HIGUCHI: "PCR Protocols", 1990, ACADEMIC PRESS, pages: 177 - 183
HOPWOOD ET AL., THE JOHN INNES FOUNDATION, NORWICH, 1985
HUBER; TORDA, PROTEIN SCIENCE, vol. 7, 1998, pages 142 - 149
ILMEN, M. ET AL., APPL. ENVIRON. MICROBIOL., vol. 63, 1997, pages 1298 - 1306
KARLIN; ALTSCHUL, PROC. NAT'L. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 5787
KARLSSON, J. ET AL., EUR. J. BIOCHEM, vol. 268, 2001, pages 6498 - 6507
KAWAGUCHI T ET AL., GENE, vol. 173, no. 2, 1996, pages 287 - 8
KNOWLES ET AL., TIBTECH, vol. 5, 1987, pages 255 - 261
KRIEGLER: "Gene Transfer and Expression: A Laboratory Manual", 1990
KRISHNA ET AL., BIORESOURCE TECH, vol. 77, 2001, pages 193 - 196
KUHLS ET AL., PNAS, vol. 93, 1996, pages 7755 - 7760
KUMAR ET AL., TEXTILE CHEMIST AND COLORIST, vol. 29, 1997, pages 37 - 42
KUNKEL ET AL., PROC. NATL. ACAD. SCI. USA, vol. 82, 1987, pages 488
LEVER, ANAL BIOCHEM, vol. 47, 1972, pages 273 - 279
LI; LJUNGDAHL, APPL. ENVIRON. MICROBIOL., vol. 62, no. L, 1996, pages 209 - 213
LINDER; TEERI, J. BIOTECHNOL., vol. 57, 1997, pages 15 - 28
LIPMAN, PROC. NAT'1 ACAD. SCI. USA, vol. 85, 1988, pages 2444
LORITO; HAYES; DIPIETRO; HARMAN, CURR. GENET., vol. 24, 1993, pages 349 - 356
LUNDHLAD: "Chemical Reagents for Protein Modification, 3rd Edition", 1984, CRC PRESS
M. E. HIMMEL ET AL.: "Fuels and Chemicals from Biomass", 1997, ACS SYMPOSIUM SERIES 666, pages: 2 - 45
MEDVE ET AL., J. CHROMATOGRAPHY A, vol. 808, 1998, pages 153 - 165
MONTENECOURT B.S., CAN., vol. 1-20, 1987
NEEDLEMAN, S. B.; WUNSCH, C. D., JOURNAL OF MOLECULAR BIOLOGY, vol. 48, 1970, pages 443 - 45
NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443
NEVALAINEN; PENTTILA, MYCOTA, 1995, pages 303 - 319
OHMIYA ET AL., BIOTECHNOL GEN ENGINEER REV, vol. 14, 1997, pages 365 - 414
OOI ET AL., NUCLEIC ACIDS RESEARCH, vol. 18, no. 19, 1990
PENTTILA ET AL., GENE, vol. 63, 1988, pages 103 - 112
PENTTILA ET AL., YEAST, vol. 3, 1987, pages 175 - 185
PENTTILA, M. ET AL., GENE, vol. 63, 1988, pages 11 - 22
PENTTILA; NEVALAINEN; RATTO; SALMINEN; KNOWLES, GENE, vol. 6, 1987, pages 155 - 164
PERE ET AL., PROC. TAPPI PULPING CONF., NASHVILLE, TENN., vol. 27-31, 1996, pages 693 - 696
POURQUIE, J. ET AL.: "Biochemistry and Genetics of Cellulose Degradation", 1988, ACADEMIC PRESS, pages: 71 - 86
ROTHSTEIN ET AL., GENE, vol. 55, 1987, pages 353 - 356
SAARILAHTI ET AL., GENE, vol. 90, 1990, pages 9 - 14
SAKAMOTO ET AL., CURR. GENET., vol. 27, 1995, pages 435 - 439
SAMBROOK ET AL.: "Molecular Cloning, A Laboratory Manual", 1989
SAMBROOK ET AL.: "MOLECULAR CLONING: A LABORATORY MANUAL(Second Edition)", 1989, COLD SPRING HARBOR PRESS
SCHELL ET AL., J APPL BIOCHEM BIOTECHNOL, vol. 105, 2003, pages 69 - 86
SCHULEIN, METHODS ENZYMOL, vol. 160, 1988, pages 234 - 243
SCOPES, METHODS ENZYMOL., vol. 90, 1982, pages 479 - 91
SHEIR-NEISS ET AL., APPL. MICROBIOL. BIOTECHNOLOGY, vol. 20, 1984, pages 46 - 53
SHOEMAKER, S. ET AL., BIO/TECHNOLOGY, vol. 1, 1983, pages 691 - 696
SINGLETON ET AL.: "DICTIONARY OF MICROBIOLOGY AND MOLECULAR BIOLOGY, 2D ED.", 1994, JOHN WILEY AND SONS
SMITH; WATERMAN, ADV. APPL. MATH., vol. 2, 1981, pages 482
SPARKS ET AL., JOURNAL OF LIPID RESEARCH, vol. 33, 1992, pages 123 - 130
SPILLIAERT R ET AL., EUR J BIOCHEM., vol. 224, no. 3, 1994, pages 923 - 30
STAHLHERG ET AL., BIO/TECHNOL., vol. 9, 1991, pages 286 - 290
SUURNAKKI ET AL., CELLULOSE, vol. 7, 2000, pages 189 - 209
TEERI, T. ET AL., GENE, vol. 51, 1987, pages 43 - 52
TE'O ET AL., FEMS MICROBIOLOGY LETTERS, vol. 190, 2000, pages 13 - 19
TILBEURGH ET AL., FEBS LETT., vol. 16, 1984, pages 215
TOMAZ; QUEIROZ, J. CHROMATOGRAPHY A, vol. 865, 1999, pages 123 - 128
TOMME ET AL., EUR. J. BIOCHEM., vol. 170, 1988, pages 575 - 581
TORMO ET AL., EMBO J., vol. 15, no. 21, 1996, pages 5739 - 5751
TYNDALL, TEXTILE CHEMIST AND COLORIST, vol. 24, 1992, pages 23 - 26
VALLETTE ET AL., NUC. ACIDS RES., vol. 17, 1989, pages 723 - 733
VAN DEN HONDEL, C. A. M. J. J. ET AL.: "More Gene Manipulations in Fungi", 1991, ACADEMIC PRESS, pages: 396 - 428
VAN HARTINGSVELDT ET AL.: "Development of a homologous transformation system for Aspergillus niger based on the pyrG gene", MOL. GEN. GENET., vol. 206, 1986, pages 71 - 75
VAN RENSBURG ET AL., YEAST, vol. 14, 1998, pages 67 - 76
VAN TILBEURGH ET AL., FEBS LETT., vol. 204, 1986, pages 223 - 227
WALSETH, TAPPI, vol. 35, 1971, pages 228
WARD ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 39, 1993, pages 738 - 743
WELLS ET AL., GENE, vol. 34, 1985, pages 315 - 323
WOOD ET AL., METHODS IN ENZYMOLOGY, vol. 160, 1988, pages 87 - 116
WOOD, BIOCHEM J, vol. 121, 1971, pages 353 - 362
WOOD, T., METHODS IN ENZYMOLOGY, vol. L60, 1988, pages 19 - 25
YELTON; HAMER; TIMBERLAKE; 1984, PROC. NATL. ACAD. SCI. USA, vol. 81, pages 1470 - 1474

Also Published As

Publication number Publication date
JP2011523854A (ja) 2011-08-25
US20120276595A1 (en) 2012-11-01
US8999692B2 (en) 2015-04-07
DK2288698T3 (en) 2017-03-20
CN102057041B (zh) 2014-10-15
US8236542B2 (en) 2012-08-07
US9695407B2 (en) 2017-07-04
AU2009256171B2 (en) 2013-11-07
US20150329842A1 (en) 2015-11-19
RU2486242C2 (ru) 2013-06-27
RU2010154437A (ru) 2012-07-20
EP2636734A3 (de) 2013-12-04
US20100041104A1 (en) 2010-02-18
WO2009149202A2 (en) 2009-12-10
CO6331367A2 (es) 2011-10-20
JP5690721B2 (ja) 2015-03-25
KR20110020243A (ko) 2011-03-02
PH12013501799A1 (en) 2018-06-25
AU2009256171A1 (en) 2009-12-10
HK1156972A1 (en) 2012-06-22
EP2628796A1 (de) 2013-08-21
WO2009149202A3 (en) 2010-04-08
MX343221B (es) 2016-10-28
EP2628795A1 (de) 2013-08-21
EP2288698A2 (de) 2011-03-02
BRPI0913624A2 (pt) 2015-08-04
CA2726357A1 (en) 2009-12-10
EP2288698B1 (de) 2016-12-21
ES2619902T3 (es) 2017-06-27
CN102057041A (zh) 2011-05-11
MX2010013099A (es) 2010-12-21
CN104312998A (zh) 2015-01-28
EP2636734A2 (de) 2013-09-11

Similar Documents

Publication Publication Date Title
US9695407B2 (en) Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials
US9523087B2 (en) Cellulase variants with improved expression, activity and stability, and use thereof
US8008056B2 (en) Variant Hypocrea jecorina CBH2 cellulases
AU2016200955A1 (en) Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials
AU2014200340A1 (en) Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130523

AC Divisional application: reference to earlier application

Ref document number: 2288698

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140215